Home
  >  
Section 43

EurekaMag Full Text Articles Chapter 42,017



References:

Rett, A. 1973: 2 year experience of clonazepam in childhood cerebral spasm seizures. Acta Neurologica Scandinavica. Supplementum 53: 109
Schindler, W.; Bredereck, G.; Raetz, M. 1970: 2 year experiment on the prevention and control of myxomatosis by the use of fly sprays and special hygienic measures. Archiv für Experimentelle Veterinarmedizin 24(2): 661-686
Lemoine, L. 1970: 2 years as Lamco-physician: tropical medicine, outland problems, medicine-men. Lakartidningen 67(18): 1988-1991
von Dewall, I. 1967: 2 years as a Peace Corps worker boosts appreciation. Tidskrift for Sveriges Sjukskoterskor 34(18): 867
von Dewall, I. 1967: 2 years as a Peace Corps worker increases appreciation. Tidskrift for Sveriges Sjukskoterskor 18: 867
Riederer, T. 1995: 2 years as a dentist in Malawi, Africa, 1992 to 1993. Schweizer Monatsschrift für Zahnmedizin 105(4): 558-560
Kammann, J.; Dornbach, G.; Cosmar, E. 1995: 2 years corneal small-incision surgery. Results and indications. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 92(3): 266-269
Reimelt, A.H. 1972: 2 years experience with cold light. Oesterreichische Dentisten Zeitschrift 24(3): 66-68
Fiume, D.; Piccini, M. 1984: 2 years experience with periodic administration of intrathecal morphine to a patient with tumor pain. Minerva Anestesiologica 50(12): 663-667
Záruba, F. 1982: 2 years in Iraq. Ceskoslovenska Dermatologie 57(2): 103-106
Gómez-Arnau 1982: 2 years in the life of a recovery room: experience at the Clínica Puerta de Hierro in Madrid. Revista Espanola de Anestesiologia y Reanimacion 29(4): 205-209
Pan, M.H. 1983: 2 years nursing education in Canton ATC. Zhonghua Hu Li Za Zhi 18(3): 190-191
Fritsche, F. 1970: 2 years of central distribution of auditory aids and ambulatory care in the Otorhinolaryngologic Clinic of the Dresden Medical Academy. Das Deutsche Gesundheitswesen 25(23): 1089-1096
Stradella, P.; Bruno, C.A. 1971: 2 years of early diagnosis of female genital oncological diseases. Minerva Ginecologica 23(3): 135-136
Froidevaux, A.; Daguet, G. 1981: 2 years of emergency digestive surgery - pathology, interventions and results. Schweizerische Medizinische Wochenschrift 111(22): 818-819
Chott, F. 1966: 2 years of exclusive use of diallyl-nor-toxiferine as relaxant in clinical anesthesia. Der Anaesthesist 15(3): 81-83
Bréhant, J.; Vermeil, G. 1970: 2 years of experience at the Necker University Hospital. What is the status of our medical information. La Presse Medicale 78(19): 895-898
Subirana, A.; Oller-Daurella, L.; Chillón, D. 1967: 2 years of experience in the treatment of epilepsy with tegretol. Revista Clinica Espanola 104(4): 336-342
Brichcín, S.; Filipová, A. 1967: 2 years of experience with cholinergolytic comas. Ceskoslovenska Psychiatrie 63(4): 248-251
Serembe, M.; D'Elia, R. 1972: 2 years of experience with disodium cromoglycate in the therapy of bronchial asthma and chronic asthmatiform bronchitis. Folia Allergologica 19(2): 112-116
Kornemann, T.R. 1973: 2 years of experience with on-line and off-line laboratory data collection and processing at the Municipal Hospital Spandau-Nord. Das Medizinische Laboratorium 26(6): 147
Fankhauser, S.; Michl, J.; Morell, B. 1974: 2 years of experiences with monocomponent insulin in diabetic patients. Helvetica Medica Acta 37(5-6): 365-366
Kügler, I.; Horatz, K. 1966: 2 years of intensive care in the anesthesia department of the Hamburg-Eppendorf University Clinic. Summary and critique. Acta Anaesthesiologica Scandinavica. Supplementum 23: 758-765
Weissel, W.; Zimmermann, E. 1968: 2 years of non-programmed chronic dialysis. Wiener Zeitschrift für Innere Medizin und ihre Grenzgebiete 49(6): 223-227
Tessier, A.; Morissette, Y. 1969: 2 years of reconstruction of the ear ossicles. L'union Medicale du Canada 98(1): 63-69
Gukovich, V.A.; Rosen, S. 1972: 2 years of stapes mobilization surgery for otoslerosis patients. On the 75th birthday of honorary member of the Academy of Medical Sciences of the USSR, Samuel Rosen. Zhurnal Ushnykh Nosovykh i Gorlovykh Boleznei 32(2): 121-122
Grözinger, K.H.; Krumhaar, D. 1965: 2 years of surgery of the extraheptic bile ducts at Heidelberg Chirurgische Universitätsklinik. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 36(9): 410-416
Scheidler, K.; Grünewald, G.; Henkel, C. 1970: 2 years of the central first aid and intensive care unit in the town hospital in Friedrichshain. Das Deutsche Gesundheitswesen 25(52): 2455-2461
Girard, V.; Picard, P.; Lefebvre, P. 1966: 2 years of use of synthetic heparinoids in the treatment of cerebral thrombosis. Gazette Medicale de France 73(3): 581-584
Dubarry, J.J. 1967: 2 years of utilizing metoclopramide in a department of gastroenterology. Journal de Medecine de Bordeaux et du Sud-Ouest 144(2): 286-289
Halhuber, M.J. 1973: 2 years of "early" rehabilitation following myocardial infarct at the clinic Höhenried. 1. Definition and problems of "additional treatment procedures". Fortschritte der Medizin 91(3): 108
Kramm, H. 1973: 2 years of "early" rehabilitation following myocardial infarct at the clinic Höhenried. 2. Organizational aspects. Fortschritte der Medizin 91(3): 109-113
Hofmann, H.; Seuberling, M. 1973: 2 years of "early" rehabilitation following myocardial infarct at the clinic Höhenried. 3. Medical aspects of additional procedures following myocardial infarct. Fortschritte der Medizin 91(3): 114-116
Guter, P. 1966: 2 years operation of relief fund of the BLZK. Bzb. Bayerisches Zahnarzteblatt 5(8): 245-248
Piñeiro Alvarez, B. 1983: 2 years personal experience in anapsos treatment of psoriasis in various clinical forms. Medicina Cutanea Ibero-Latino-Americana 11(1): 65-72
Dunovský, J.; Karabelová, H. 1995: 2 years' activity of the Crisis Center for Children in the care of battered, abused and neglected children. Casopis Lekaru Ceskych 134(11): 347-348
Novakovic, A.; Vujosevic, E.; Alajbegovic, R.; Hodzic, S. 1982: 2 years' administration of timolol to patients with chronic open-angle glaucoma. Bulletin des Societes d'Ophtalmologie de France 82(3): 311-312
Barker, P.; Jamieson, R. 1967: 2 years' admissions to a regional child psychiatry unit. British Medical Journal 2(5544): 103-106
Osterberg, S. 1967: 2 years' experience in a group practice: stimulating cooperation and comfort. Lakartidningen 64(8): 781-786
Groshikov, M.I.; Varennikov, S.I.; Maksimovskiĭ, I.M. 1980: 2 years' experience in conducting an internship in therapeutic stomatology. Stomatologiia 59(4): 76
Paráz Chavero, E.; Hervella Pérez, L.; Lorenzo, J.A.; Carrillo López, L.; Martínez, J.; Benítez, J. 1970: 2 years' experience in the coronary unit. Archivos del Instituto de Cardiologia de Mexico 40(6): 785-796
Durnov, L.A.; Nikolaeva, T.N.; Andreeva, T.S.; Riabov, A.I. 1966: 2 years' experience in the work of the Children's Oncological Department. Voprosy Onkologii 12(2): 70-75
Toro, E.; Sigala, I.; Chávez, F. 1980: 2 years' experience with a special food formula for premature infants. Revista Chilena de Pediatria 51(4): 266-269
Wennig, R. 1981: 2 years' experience with laboratory of chemical toxicology and pharmacology in the framework of emergency toxicology in Luxembourg. Bulletin de la Societe des Sciences Medicales du Grand-Duche de Luxembourg 118(2): 23-27
Bouillenne, J.C. 1970: 2 years' experience with local treatment by 5-fluorouracil. Archives Belges de Dermatologie et de Syphiligraphie 26(1): 33-37
Gregori Júnior, F.; Silva, S.S.; Ribeiro, I.A.; Kreling, P.A.; Façanha, L.A.; Campos, M.; Goulart, M.L.; Miguita, L.C.; Gois, L.E.; Ochiro, L. 1982: 2 years' experience with mitral valvuloplasties. Arquivos Brasileiros de Cardiologia 39(4): 263-267
Hörauf, K. 1967: 2 years' experience with the stomascop. Die Quintessenz 18(4): 63-65
Gerhardt, H.J.; Tietz, C. 1967: 2 years' results of 267 stapes (platic repairs) by Zangemeister-Heerman method. Hno 15(12): 353-357
Herman, D.; Dry, J. 1973: 2 years' use of sodium cromoglycate. Therapie 28(6): 1111-1121 Passim
Roques, J.F. 1966: 2 years' use of the Midwest Air rotor equipment. Ujcd. Union des Jeunes Chirurgiens-Dentistes 22: 34-35
Kondo, S.; Horiuchi, Y.; Ikeda, D.; Gomi, S.; Hotta, K.; Okami, Y.; Umezawa, H. 1982: 2"-N-formimidoylistamycin A and B produced by Streptomyces tenjimariensis. Journal of Antibiotics 35(8): 1104-1106
Rodríguez Miñón, J.L.; Arrieta Alvarez, F. 1965: 2 "sisters" with feminizing testicle. Revista Clinica Espanola 97(4): 268-272
Cerná, J.; Rychlík, I.; Krayevsky, A.A.; Gottikh, B.P. 1973: 2' (3')-O-N-formylmethionyl)-adenosine-5'-phosphate, a new donor substrate in peptidyl transferase catalyzed reactions. Febs Letters 37(2): 188-191
Jurjus, A.R.; Ridgeway, A.; Witz, I.P. 1984: 2' Deoxycoformycin and human hemopoietic cells in culture. Developmental and Comparative Immunology 8(4): 931-937
Scavennec, J.; Cailla, H.; Gastaut, J.A.; Maraninchi, D.; Carcassonne, Y. 1982: 2' and 3' ribonucleoside monophosphate in leukocytes of acute myeloid leukemia: markers for early diagnosis of relapse. International Journal of Cancer 29(3): 257-259
Raes, I.; Weissbarth, S.; Maker, H.S.; Lehrer, G.M. 1981: 2', 3'-cyclic nucleotide 3'-phosphodiesterase in cerebrospinal fluid. Neurology 31(10): 1361-1363
Komiya, Y.; Kasahara, M. 1971: 2', 3'-cyclic nucleotide 3'-phosphohydrolase activity in myelin fractions from one patient with Schilder's disease. Journal of Biochemistry 70(2): 371-374
Fan, K. 1980: 2', 3'-cyclic nucleotide 3'-phosphohydrolase activity in postmortem human spinal fluids. Neuroscience Letters 19(2): 229-233
Nilsen, T.W.; McCandless, S.; Baglioni, C. 1982: 2', 5'-oligo(A)-activated endonuclease in NIH 3T3 mouse cells chronically infected with Moloney murine leukemia virus. Virology 122(2): 498-502
Mezei, C.; Mezei, M.; Hawkins, A. 1974: 2',3'-Cyclic AMP 3'-phosphohydrolase activity during Wallerian degeneration. Journal of Neurochemistry 22(3): 457-458
Müller, H.W.; Seifert, W. 1982: 2',3'-Cyclic nucleotide 3'-phosphodiesterase (CNPase) activity in cultured nerve cell lines from central nervous system: comparison of proliferating and resting growth states and cell cycle-dependent activity changes. Cellular and Molecular Neurobiology 2(3): 227-239
Suda, H.; Hosokawa, T.; Ohno, R.; Hamaguchi, K.; Tsukada, Y. 1984: 2',3'-Cyclic nucleotide 3'-phosphodiesterase activity in the cerebrospinal fluid of patients with demyelinating diseases. Neurochemical Pathology 2(2): 85-102
Kurihara, T.; Kawakami, S.; Ueki, K.; Takahashi, Y. 1974: 2',3'-Cyclic nucleotide 3'-phosphohydrolase activity in human brain tumours. Journal of Neurochemistry 22(6): 1143-1144
Pechan, I.; Simekova, J. 1972: 2',3'-Cyclic nucleotide 3'-phosphohydrolase activity of the central nervous tissue in experimental allergic encephalomyelitis. Journal of Neurochemistry 19(2): 557-558
Göpfert, E.; Pytlik, S.; Debuch, H. 1980: 2',3'-Cyclic nucleotide 3'-phosphohydrolase and lipids of myelin from multiple sclerosis and normal brains. Journal of Neurochemistry 34(3): 732-739
Belton, N.R.; Anderson, J.M. 1973: 2',3'-Cyclic nucleotide 3'-phosphohydrolase in the developing human brain. Archives of Disease in Childhood 48(4): 325
Chidgeavadze, Z.G.; Beabealashvilli, R.S.; Atrazhev, A.M.; Kukhanova, M.K.; Azhayev, A.V.; Krayevsky, A.A. 1984: 2',3'-Dideoxy-3' aminonucleoside 5'-triphosphates are the terminators of DNA synthesis catalyzed by DNA polymerases. Nucleic Acids Research 12(3): 1671-1686
Burkhart, B.M.; Papchikhin, A.; Chattopadhyaya, J.; Sundaralingam, M. 1995: 2',3'-Dideoxy-3'-C,2'-N-[(3R,5R)-5-ethoxy-carbonyl-2-methyl-1, 2-isoxazolidine]-ribothymidine. Acta Crystallographica. Section C Crystal Structure Communications 51: 1462-1464
Krayevsky, A.; Kukhanova, M.; Alexandrova, L.; Belyakova, N.; Krutyakov, V. 1984: 2',3'-Dideoxy-3'-aminonucleoside 5'-triphosphates inhibit the repair of DNA in rat liver chromatin. Biochimica et Biophysica Acta 783(3): 216-220
Johansson, M.; Karlsson, A. 1994: 2',3'-Dideoxycytidine phosphorylation by recombinant mouse and human deoxycytidine kinase. Advances in Experimental Medicine and Biology 370: 711-714
Belda Mira, A.; Pascual Izuel, J.M.; Gonzalvo Bellver, F.; Rovira Daudí, E. 1995: 2',3'-Dideoxyinosine and pancreatic disease in HIV infection. Medicina Clinica 104(8): 319
Cerná, J.; Chládek, S.; Rychlík, I.; Zemlicka, J. 1970: 2',3'-O-bis-L-aminoacyladenosines and 2'(3')-O-L-phenylalanyl-L-phenylalanyladenosine: new acceptor substrates for peptidyltransferase. Biochimica et Biophysica Acta 199(1): 291-293
Ogilvie, K.K.; Slotin, L. 1971: 2',3'-carbonates of 8-hydroxypurine nucleosides. Journal of Organic Chemistry 36(17): 2556-2558
Hof, L.; Csiza, C.K.; Dentinger, M.P.; Barron, K.D. 1984: 2',3'-cyclic nucleotide 3'-phosphodiesterase and 5'-nucleotidase in the central nervous system of a myelin-deficient rat mutant. Journal of Neurochemistry 42(6): 1767-1770
Braun, P.E.; Barchi, R.L. 1972: 2',3'-cyclic nucleotide 3'-phosphodiesterase in the nervous system. Electrophoretic properties and developmental studies. Brain Research 40(2): 437-444
Kurihara, T.; Nussbaum, J.L.; Mandel, P. 1970: 2',3'-cyclic nucleotide 3'-phosphohydrolase in brains of mutant mice with deficient myelination. Journal of Neurochemistry 17(7): 993-997
Sudo, T.; Kikuno, M.; Kurihara, T. 1972: 2',3'-cyclic nucleotide 3'-phosphohydrolase in human erythrocyte membranes. Biochimica et Biophysica Acta 255(2): 640-646
Kurihara, T.; Nussbaum, J.L.; Mandel, P. 1971: 2',3'-cyclic nucleotide 3'-phosphohydrolase in purified myelin from brain of Jimpy and normal young mice. Life Sciences.(Part 2): Biochemistry General and Molecular Biology 10(8): 421-429
Dreiling, C.E.; Schilling, R.J.; Reitz, R.C. 1981: 2',3'-cyclic nucleotide 3'-phosphohydrolase in rat liver mitochondrial membranes. Biochimica et Biophysica Acta 640(1): 114-120
Kurihara, T.; Nussbaum, J.L.; Mandel, P. 1969: 2',3'-cyclic nucleotide 3'-phosphohydrolase in the brain of the "Jimpy" mouse, a mutant with deficient myelination. Brain Research 13(2): 401-403
Nilsen, T.W.; Wood, D.L.; Baglioni, C. 1981: 2',5'-Oligo(A)-activated endoribonuclease. Tissue distribution and characterization with a binding assay. Journal of Biological Chemistry 256(21): 10751-10754
Sawai, H.; Ishibashi, K.; Itoh, M.; Watanabe, S. 1984: 2',5'-Oligoadenylate and 2',5'-oligoadenylate phosphodiesterase in human plasma. Biochemical and Biophysical Research Communications 125(3): 1061-1066
Black, P.L.; Henderson, E.E.; Pfleiderer, W.; Charubala, R.; Suhadolnik, R.J. 1984: 2',5'-Oligoadenylate trimer core and the cordycepin analog augment the tumoricidal activity of human natural killer cells. Journal of Immunology 133(5): 2773-2777
Hughes, B.G.; Srivastava, P.C.; Muse, D.D.; Robins, R.K. 1983: 2',5'-Oligoadenylates and related 2',5'-oligonucleotide analogues. 1. Substrate specificity of the interferon-induced murine 2',5'-oligoadenylate synthetase and enzymatic synthesis of oligomers. Biochemistry 22(9): 2116-2126
Hughes, B.G.; Robins, R.K. 1983: 2',5'-Oligoadenylates and related 2',5'-oligonucleotide analogues. 2. Effect on cellular proliferation, protein synthesis, and endoribonuclease activity. Biochemistry 22(9): 2127-2135
Suhadolnik, R.J.; Flick, M.B.; Mosca, J.D.; Sawada, Y.; Doetsch, P.W.; Vonderheid, E.C. 1983: 2',5'-oligoadenylate synthetase from cutaneous T-cell lymphoma: biosynthesis, identification, quantitation, molecular size of the 2',5'-oligoadenylates, and inhibition of protein synthesis. Biochemistry 22(17): 4153-4158
Ball, L.A.; West, D.K. 1981: 2',5'-oligoadenylate synthetase in interferon-treated chick cells. Texas Reports on Biology and Medicine 41: 487-492
Simuth, J.; Strehlke, P.; Niedballa, U.; Vorbrüggen, H.; Scheit, K.H. 1971: 2'-0-methylcytidine 5'-diphosphate as substrate for polynucleotide phosphorylase from Escherichia coli. Biochimica et Biophysica Acta 228(3): 654-663
Mikoshiba, K.; Aoki, E.; Tsukada, Y. 1980: 2'-3'-cyclic nucleotide 3'-phosphohydrolase activity in the central nervous system of a myelin deficient mutant (Shiverer). Brain Research 192(1): 195-204
Koliais, S.I.; Kortsaris, A. 1982: 2'-5' oligo(A) synthetase levels in interferon-sensitive or -resistant lymphoid cells. Journal of General Virology 58 Pt 1: 191-193
Nakazato, H.; Ikeda, M. 1995: 2'-5' olygoadenylate synthetase activity in peripheral facial paralysis. Nihon Jibiinkoka Gakkai Kaiho 98(3): 457-464
Goswami, B.B.; Crea, R.; Van Boom, J.H.; Sharma, O.K. 1982: 2'-5'-Linked oligo(adenylic acid) and its analogs. a new class of inhibitors of mRNA methylation. Journal of Biological Chemistry 257(12): 6867-6870
Ishihama, A.; Enami, M.; Nishijima, Y.; Fukui, T.; Ohtsuka, E.; Ikehara, M. 1980: 2'-Deoxy-2'-azidoadenosine triphosphate and 2'-deoxy-2'-fluoroadenosine triphosphate as substrates and inhibitors for Escherichia coli DNA-dependent RNA polymerase. Journal of Biochemistry 87(3): 825-830
Tolkovsky, A.M. 1980: 2'-Deoxyadenosine functionally uncouples adenylate cyclase from the guanyl nucleotide subunit without altering simultaneous GppNHp occupancy. Febs Letters 116(2): 165-168
Spremulli, E.; Crabtree, G.W.; Dexter, D.L.; Diamond, I.; Calabresi, P. 1982: 2'-Deoxycoformycin-induced hemolysis in the mouse. Journal of the National Cancer Institute 68(6): 1011-1014
Juca, M.B.; Aoyama, H. 1995: 2'-Fluoropolynucleotide-directed reverse transcriptase reactions. Effect of homologous polynucleotides. Journal of Enzyme Inhibition 8(4): 261-265
Bennett, G.N.; Mackey, J.K.; Wiebers, J.L.; Gilham, P.T. 1973: 2'-O-(alpha-methoxyethyl)nucleoside 5'-diphosphates as "single-addition" substrates in the synthesis of specific oligoribonucleotides with polynucleotide phosphorylase. Biochemistry 12(20): 3956-3962
Dunlap, B.E.; Friderici, K.H.; Rottman, F. 1971: 2'-O-Methyl polynucleotides as templates for cell-free amino acid incorporation. Biochemistry 10(13): 2581-2587
Reese, C.B.; Trentham, D.R. 1965: 2'-O-acyl ribonucleoside derivatives. Tetrahedron Letters 29: 2459-2465
Raviprakash, K.S.; Cherayil, J.D. 1984: 2'-O-methyl-1-methyl adenosine: a new modified nucleoside in ragi (Eleusine coracana) tRNA. Biochemical and Biophysical Research Communications 121(1): 243-248
Gerard, G.F.; Rottman, F.; Boezi, J.A. 1971: 2'-O-methyladenosine 5'-triphosphate. a substrate for deoxyribonucleic acid dependent ribonucleic acid polymerase of Pseudomonas putida. Biochemistry 10(11): 1974-1981
Kimeral, R.E.; Fedorov, N.A. 1973: 2'-O-methylation of 18S and 28S rRNA of human lymphocytes in normal conditions and in chronic lympholeukosis. Doklady Akademii Nauk SSSR 210(5): 1220-1222
Al-Arif, A.; Sporn, M.B. 1972: 2'-O-methylation of adenosine, guanosine, uridine, and cytidine in RNA of isolated rat liver nuclei. Proceedings of the National Academy of Sciences of the United States of America 69(7): 1716-1719
Price, A.R.; Rottman, F. 1970: 2'-O-methyloligoadenylates as templates for the binding of lysyl transfer ribonucleic acid to ribosomes. Biochemistry 9(23): 4524-4529
Chwang, T.L.; Fridland, A.; Avery, T.L. 1983: 2'-O-nitro-1-beta-D-arabinofuranosylcytosine. a new derivative of 1-beta-D-arabinofuranosylcytosine that resists enzymatic deamination and has antileukemic activity. Journal of Medicinal Chemistry 26(2): 280-283
Verhaegen-Lewalle, M.; Content, J. 1982: 2'-Phosphodiesterase activity in human cell lines treated or untreated with human interferon. European Journal of Biochemistry 126(3): 639-643
Gray, D.P.; Grever, M.R.; Siaw, M.F.; Coleman, M.S.; Balcerzak, S.P. 1982: 2'-deoxycoformycin (DCF) and 9-beta-D-arabinofuranosyladenine (Ara-A) in the treatment of refractory acute myelocytic leukemia. Cancer Treatment Reports 66(2): 253-257
Poster, D.S.; Penta, J.S.; Bruno, S.; Macdonald, J.S. 1981: 2'-deoxycoformycin. a new anticancer agent. Cancer Clinical Trials 4(2): 209-213
Sidi, Y.; Mitchell, B.S. 1984: 2'-deoxyguanosine toxicity for B and mature T lymphoid cell lines is mediated by guanine ribonucleotide accumulation. Journal of Clinical Investigation 74(5): 1640-1648
Lopez, C.; Watanabe, K.A.; Fox, J.J. 1980: 2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent. Antimicrobial Agents and ChemoTherapy 17(5): 803-806
Wurm, G.; Lachmann, C. 1974: 2'-hydroxychalcone and 3-hydroxyflavone sulfonic acid derivatives. Archiv der Pharmazie 307(9): 695-700
Krishnan, I.; Baglioni, C. 1980: 2'5' oligo(A) polymerase activity in serum of mice infected with EMC virus or treated with interferon. Nature 285(5765): 485-488
Justesen, J.; Ferbus, D.; Thang, M.N. 1980: 2'5' oligoadenylate synthetase, an interferon induced enzyme: direct assay methods for the products, 2'5' oligoadenylates and 2'5' co-oligonucleotides. Nucleic Acids Research 8(14): 3073-3085
Marti, J.; Fournie, P.; Lafont, J. 1982: 2'5'-Oligoadenylate polymerase activity in the rat small intestine. Differentiation; Research in Biological Diversity 22(3): 201-204
Orlic, D.; Quaini, F.; Konski, A.A.; Wu, J.M. 1982: 2'5'-adenylate inhibition of erythropoietin-dependent colony formation. Stem Cells 1(4-5): 261-268
Foster, P.C.; Carey, E.M. 1980: 2':3'-Cyclic nucleotide 3'-phosphohydrolase activity in human infant corpus callosum. Biochemical Society Transactions 8(5): 610-611
Gakis, C.; Piras, M.A.; Saba, F.; Romani, G.; Longinotti, M. 1981: 2'Deoxyadenosine/adenosine deaminase ratio in pleural and peritoneal effusions. Diagnostic significance. Bollettino della Societa Italiana di Biologia Sperimentale 57(18): 1835-1841
Donner, A.L.; Leyland-Jones, B. 1984: 2'Fluoro-5-iodo-arabinosyl-cytosine: a new agent for herpes infections in the immunosuppressed patient. Drug Intelligence and Clinical Pharmacy 18(11): 885-888
De Céspedes, C.; Jiménez, R.; Jiménez, E.; Mora, L.A.; Carrillo, J.M. 1981: 2, 3 DPG in anemic children. Sangre 26(4): 515-516
Chiba, H.; Ikura, K.; Sasaki, R.; Sugimoto, E.; Saimyoji, H. 1974: 2, 3-Diphosphoglycerate and phosphoglycerate mutase levels in animal tissues and erythrocytes. Journal of Biochemistry 76(1): 91-97
Liublinskaia, L.A.; Vaganova, T.I.; Paskhina, T.S.; Stepanov, V.M. 1973: 2, 4-Dinitrophenyl peptide derivatives, a new type of substrate for determining the activity of proteolytic enzymes. the determination of carboxypeptidase activity. Biokhimiia 38(4): 790-795
Taleb, A.; Belkhodja, A.; Zidane, C.; Boulahbal, M.; Colonna, P.; Messerschmitt, J. 1967: 2,000 cases of anemia in adults observed in four years. La Tunisie Medicale 45(4): 249-257
Gauthier, R.A.; Hassels, A. 1968: 2,000 hospital workers answer questions about cancer. American Journal of Nursing 68(10): 2177-2180
Baum, A.Z. 1970: 2,000 men--and two nurses. Rn 33(8): 32-35
Dubost, C.; Blondeau, P.; D'Allaines, C.; Piwnica, A.; Passelecq, J.; Guery, J.; Sprovieri, L. 1965: 2,000 open heart operations. Annales de Chirurgie Thoracique et Cardio-Vasculaire 4(3): 410-422
Inou, T. 1967: Present and future of kidney transplantation. Geka Chiryo. Surgical Therapy 16(4): 447-452
Coventry, M.B.; Beckenbaugh, R.D.; Nolan, D.R.; Ilstrup, D.M. 1974: 2,012 total hip arthroplasties. a study of postoperative course and early complications. Journal of Bone and Joint Surgery. American Volume 56(2): 273-284
Böhme, H.; Laun, H.; Haack, B. 1972: 2,2 and 1,2-Bisaralkylmercapto- and -aralkylsulfonylpropanes. Archiv der Pharmazie 305(9): 637-644
Linden, A.; Lee, C.K. 1995: 2,2',3,3'-Tetra-O-benzoyl-6,6'-dideoxy-4,4'-di-O-mesyl-6,6'- dithiocyanato-alpha,alpha-trehalose. Acta Crystallographica. Section C Crystal Structure Communications 51: 751-754
Preston, B.D.; Allen, J.R. 1980: 2,2',5,5'-Tetrachlorobiphenyl: isolation and identification of metabolites generated by rat liver microsomes. Drug Metabolism and Disposition: the Biological Fate of Chemicals 8(4): 197-204
Carter, S.K. 1968: 2,2'-(9,10-anthrylenedimethylene)bis[2-thiopseudourea], dihydrochloride, dihydrate (NSC-56054)--clinical brochure. Cancer ChemoTherapy Reports. Part 1(1): 153-163
Kreutzberger, A.; Schüker, R. 1972: 2,2'-Azoimidazoles as potential cytostatic agents. 9. Condensations with hydrazin-N,N'-dicarbonic acid diamidine. Arzneimittel-Forschung 22(10): 1723-1724
Eiden, F.; Prielipp, L. 1974: 2,2'-Bi-4-pyrones. Archiv der Pharmazie 307(6): 461-465
Hoshi, A.; Kanazawa, F.; Kuretani, K.; Saneyoshi, M.; Arai, Y. 1971: 2,2'-O-cyclocytidine, an antitumor cytidine analog resistant to cytidine deaminase. Gan 62(2): 145-146
Kreutzberger, A.; Schücker, R. 1972: 2,2'-azoimidazole formation by cyclic acyloins. 8. Condensations with hydrazine-N,N'-dicarboxamidine. Archiv der Pharmazie 305(6): 400-405
Novelli, A.; Ferrari, V.; Alonso, O.; Barrio, J.R. 1971: 2,2'-dialkoxybenzhydrylamides and 2,2'-dialkylbenzhydryl esters of N,N-edisubstituted alpha-amino acids. Synthesis and pharmacological evaluation. Journal of Medicinal Chemistry 14(1): 78-80
Avramoff, M. 1968: 2,2'-hydrazobis(5-nitropyrimidines). Journal of Medicinal Chemistry 11(5): 1106-1107
Weygand, F.; Tschesche, H. 1969: 2,2,2-Trifluoro-1-(2-ureido-ethanesulfonyl)-N-benzoylethylamine, a reagent for blocking lysine residues in proteins against tryptic hydrolysis. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 350(1): 93-94
Hendric, W.R.; Thomas, J.A.; Mathew, A.; Zimbrick, J.D. 1981: 2,2,5,5-tetramethyl-1-pyrrolidinyl-oxy-3-carboxylic acid (PCA) as a potential radiosensitizer iv vivo. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 40(4): 451-454
Shannahoff, D.H.; Sanchez, R.A. 1973: 2,2-Anhydropyrimidine nucleosides. Novel syntheses and reactions. Journal of Organic Chemistry 38(3): 593-598
Cook, J.C.; Hodgson, E. 1984: 2,2-Dimethyl-5-t-butyl-1,3-benzodioxole: an unusual inducer of microsomal enzymes. Biochemical Pharmacology 33(24): 3941-3946
Settine, R.L.; Lewis, J.B.; Mayne, R.; Hedrick, G.W. 1968: 2,2-dimethyl-3-vinylcyclobutaneacetic acid, a fungistatic agent derived from pinene. Journal of Medicinal Chemistry 11(5): 955-957
Syvertsen, C.; McKinley-McKee, J.S. 1984: 2,2-dipyridyl binding to metal substituted horse liver alcohol dehydrogenase. Journal of Inorganic Biochemistry 22(1): 43-53
Jesch, F.; Webber, L.M.; Dalton, J.W.; Carey, J.S. 1974: 2,3 Diphosphoglycerate and oxygen affinity of hemoglobin after whole blood infusion, preserved with ACD and CPD. Langenbecks Archiv für Chirurgie Suppl: 175-178
Ludwiczak, H.; Przybylska, H.; Skotnicka-Fedorowicz, B. 1982: 2,3 bisphosphoglycerate in children with diabetes mellitus. Preliminary report. Pediatria Polska 57(4): 217-221
Gelb, S.; Waxman, H.S. 1971: 2,3 diphosphoglyceric acid and the delivery of oxygen by red blood cells. American Journal of Medical Technology 37(12): 480-484
Marquet, J.P.; Andre-Louisfert, J.; Bisagni, E. 1969: 2,3 disubstituted furans and pyrroles. 8. new method for the syntheses of furo(2,3-d) pyrimidines substituted in the 4 position and certain thieno(2,3-d)pyrimidines. Bulletin de la Societe Chimique de France (12): 4344-4348
Bisagni, E.; Marquet, J.P.; Andre-Louisfert, J. 1969: 2,3 disubstituted furans and pyrroles. VII. Generalization of a new procedure for the syntheses of pyrrolo(2,3-d)pyrimidines. Bulletin de la Societe Chimique de France (12): 4338-4344
Bartlett, P.D.; Purrington, S.T. 1966: 2,3',5',6-Tetra-t-butylindophenoxyl, competitive scavenging, and isoope effects. Journal of the American Chemical Society 88(14): 3303-3309
Parkinson, A.; Robertson, L.; Uhlig, L.; Campbell, M.A.; Safe, S. 1982: 2,3,4,4'-Pentachlorobiphenyl: differential effects on C57BL/6J and DBA/2J inbred mice. Biochemical Pharmacology 31(17): 2830-2833
Kunstmann, R.; Lerch, U.; Gerhards, H.; Leven, M.; Schacht, U. 1984: 2,3,4,4a,5,9b-Hexahydro-1H-indeno[1,2-b]pyridines: potential antidepressants. Journal of Medicinal Chemistry 27(4): 432-439
Marshall, F.N. 1972: 2,3,5,6-tetrachloro-4-pyridinol: a new chemical structure for anticoagulant activity. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 139(1): 223-227
Ness, R.K.; Fletcher, H.G.; Freer, K.W. 1971: 2,3,5-Tri-O-benzoyl-1-O-(p-nitrobenzoyl)- -D-ribofuranose, a convenient reagent for the preparation of 2,3,5-tri-O-benzoyl-D-ribofuranosyl chloride and bromide. Carbohydrate Research 19(3): 423-429
Wada, G.H.; Fellman, J.H. 1973: 2,3,5-Trihydroxyphenylacetic acid. a metabolite of L-3,4-dihydroxyphenylalanine. Biochemistry 12(25): 5212-5217
Yoshimoto, T.; Yokoyama, C.; Ochi, K.; Yamamoto, S.; Maki, Y.; Ashida, Y.; Terao, S.; Shiraishi, M. 1982: 2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Biochimica et Biophysica Acta 713(2): 470-473
Linford, J.H. 1973: 2,3,5-Tris-ethylenimino-1,4-benzoquinone (Trenimon): some chemical and biological properties. Chemico-Biological Interactions 6(3): 149-168
Avakian, A.O. 1968: 2,3,5-triphenyltetrazolium chloride (TTC) as an indicator for hygienic assessment of raw, semi-prepared and prepared meat and fish products. Voprosy Pitaniia 27(3): 82-84
Sipes, I.G.; Slocumb, M.L.; Chen, H.S.; Carter, D.E. 1982: 2,3,6,2',3',6'-hexachlorobiphenyl: distribution, metabolism, and excretion in the dog and the monkey. Toxicology and Applied Pharmacology 62(2): 317-324
Rosenberg, A. 1984: 2,3,6-Trichlorophenylacetic acid (fenac) degradation in aqueous and soil systems. Bulletin of Environmental Contamination and Toxicology 32(4): 383-390
Matsuhiro, B.; Furst, A. 1970: 2,3,6-Trimethoxynitrostyrene and its beta-phenethylamine. Journal of Medicinal Chemistry 13(5): 973
Milstone, L.M.; LaVigne, J.F. 1984: 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces hyperplasia in confluent cultures of human keratinocytes. Journal of Investigative Dermatology 82(5): 532-534
Gross, M.L.; Lay, J.O.; Lyon, P.A.; Lippstreu, D.; Kangas, N.; Harless, R.L.; Taylor, S.E.; Dupuy, A.E. 1984: 2,3,7,8-Tetrachlorodibenzo-p-dioxin levels in adipose tissue of Vietnam veterans. Environmental Research 33(1): 261-268
Whitlock, J.P.; Galeazzi, D.R. 1984: 2,3,7,8-Tetrachlorodibenzo-p-dioxin receptors in wild type and variant mouse hepatoma cells. Nuclear location and strength of nuclear binding. Journal of Biological Chemistry 259(2): 980-985
Pratt, R.M.; Dencker, L.; Diewert, V.M. 1984: 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced cleft palate in the mouse: evidence for alterations in palatal shelf fusion. Teratogenesis Carcinogenesis and Mutagenesis 4(5): 427-436
Tofilon, P.J.; Piper, W.N. 1982: 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated depression of rat testicular heme synthesis and microsomal cytochrome P-450. Biochemical Pharmacology 31(22): 3663-3666
Poland, A.; Glover, E. 1973: 2,3,7,8-Tetrachlorodibenzo-p-dioxin: a potent inducer of -aminolevulinic acid synthetase. Science 179(4072): 476-477
Knutson, J.C.; Poland, A. 1984: 2,3,7,8-Tetrachlorodibenzo-p-dioxin: examination of biochemical effects involved in the proliferation and differentiation of XB cells. Journal of Cellular Physiology 121(1): 143-151
Knutson, J.C.; Poland, A. 1980: 2,3,7,8-Tetrachlorodibenzo-p-dioxin: failure to demonstrate toxicity in twenty-three cultured cell types. Toxicology and Applied Pharmacology 54(3): 377-383
Decad, G.M.; Birnbaum, L.S.; Matthews, H.B. 1981: 2,3,7,8-Tetrachlorodibenzofuran tissue distribution and excretion in guinea pig. Toxicology and Applied Pharmacology 57(2): 231-240
Shiverick, K.T.; Muther, T.F. 1983: 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) effects on hepatic microsomal steroid metabolism and serum estradiol of pregnant rats. Biochemical Pharmacology 32(6): 991-995
Poland, A.; Knutson, J.C. 1982: 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annual Review of Pharmacology and Toxicology 22: 517-554
Gerber, G.; Holzhütter, H.; Röseler, E.; Rapoport, I.; Elsner, R. 1981: 2,3-Biphosphoglycerate, inorganic phosphate, pH and hemoglobin concentration in chronic renal failure of man. Acta Biologica et Medica Germanica 40(4-5): 711-715
Narita, H.; Ikura, K.; Yanagawa, S.; Sasaki, R.; Chiba, H.; Saimyoji, H.; Kumagai, N. 1980: 2,3-Bisphosphoglycerate in developing rabbit erythroid cells. Journal of Biological Chemistry 255(11): 5230-5235
Hamasaki, N. 1984: 2,3-Bisphosphoglycerate inhibits the transport of phosphoenolpyruvate across the erythrocyte membrane. Biochemical and Biophysical Research Communications 122(2): 609-612
Kuehnle, J.; Holzbaur, J. 1983: 2,3-Butanediol in serum of alcoholics. Lancet 2(8363): 1369-1370
Faure Nogueras, E.; Millastre Benito, A.; Blasco Comenge, M.C.; García Alvarez, F.; Gutiérrez Martín, M. 1981: 2,3-DPG and diabetic microangiopathy. Revista Clinica Espanola 163(4): 227-230
Brewer, G.J. 1974: 2,3-DPG and erythrocyte oxygen affinity. Annual Review of Medicine 25: 29-38
Jelkmann, W.; Bauer, C. 1980: 2,3-DPG levels in relation to red cell enzyme activities in rat fetuses and hypoxic newborns. Pflugers Archiv: European Journal of Physiology 389(1): 61-68
Duhm, J. 1973: 2,3-DPG-induced displacements of the oxyhemoglobin dissociation curve of blood: mechanisms and consequences. Advances in Experimental Medicine and Biology 37a: 179-186
Kumar, V.; Kessler, J.; Scott, M.E.; Patwardhan, B.H.; Tanenbaum, S.W.; Flashner, M. 1981: 2,3-Dehydro-4-epi-N-acetylneuraminic acid; a neuraminidase inhibitor. Carbohydrate Research 94(2): 123-130
Knirel, Y.A.; Kocharova, N.A.; Shashkov, A.S.; Dmitriev, B.A.; Kochetkov, N.K. 1981: 2,3-Diacetamido-2,3-dideoxy-D-glucuronic acid: a new acidic amino sugar from Pseudomonas aeruginosa type O6 lipopolysaccharide. Carbohydrate Research 93(1): C12-C13
Knirel, Y.A.; Vinogradov, E.V.; Shashkov, A.S.; Dmitriev, B.A.; Kochetkov, N.K. 1982: 2,3-Diacetamido-2,3-dideoxy-D-mannuronic acid and its 2-imidazoline derivative: new acidic amino sugars from Pseudomonas aeruginosa O: 3a,d lipopolysaccharide. Carbohydrate Research 104(1): C4-C7
Ennis, H.L.; Möller, L.; Wang, J.J.; Selawry, O.S. 1971: 2,3-Dihydro-1H-imidazo(1,2-b)pyrazole: a new inhibitor of deoxyribonucleic acid synthesis. Biochemical Pharmacology 20(10): 2639-2646
Raistrick, H.; Rice, F.H. 1971: 2,3-Dihydro-3,6-dihydroxy-2-methyl-4-pyrone and curvularin from Penicillium gilmanii. Journal of the Chemical Society. Perkin Transactions 1 18: 3069-3070
Closse, A.; Haefliger, W.; Hauser, D.; Gubler, H.U.; Dewald, B.; Baggiolini, M. 1981: 2,3-Dihydrobenzofuran-2-ones: a new class of highly potent antiinflammatory agents. Journal of Medicinal Chemistry 24(12): 1465-1471
Ribbons, D.W.; Senior, P.J. 1970: 2,3-Dihydroxybenzoate 3,4-oxygenase from Pseudomonas fluorescens: determination of the site of ring cleavage with a substrate analogue. Biochemical Journal 117(2): 28P-29P
Young, I.G.; Cox, G.B.; Gibson, F. 1967: 2,3-Dihydroxybenzoate as a bacterial growth factor and its route of biosynthesis. Biochimica et Biophysica Acta 141(2): 319-331
Andreoni, V.; Canonica, L.; Galli, E.; Gennari, C.; Treccani, V. 1981: 2,3-Dihydroxybenzoate pathway in Pseudomonas putida. 1H n.m.r. study on the ring-cleavage site. Biochemical Journal 194(2): 607-610
Cox, G.B.; Gibson, F. 1967: 2,3-Dihydroxybenzoic acid, a new growth factor for multiple aromatic auxotrophs. Journal of Bacteriology 93(1): 502-503
Lenz, K.; Hruby, K.; Druml, W.; Eder, A.; Gaszner, A.; Kleinberger, G.; Pichler, M.; Weiser, M. 1981: 2,3-Dimercaptosuccinic acid in human arsenic poisoning. Archives of Toxicology 47(3): 241-243
Moretti, J.L.; Rapin, J.R.; Saccavini, J.C.; Lageron, A.; Le Poncin, M.; Bardy, A. 1984: 2,3-Dimercaptosuccinic-acid chelates--1. Structure and pharmacokinetic studies. International Journal of Nuclear Medicine and Biology 11(3-4): 270-274
Moretti, J.L.; Rapin, J.R.; Saccavini, J.C.; Lageron, A.; Le Poncin, M.; Bardy, A. 1984: 2,3-Dimercaptosuccinic-acid chelates--2. Renal localization. International Journal of Nuclear Medicine and Biology 11(3-4): 275-279
Lin, T.S.; Antonini, I.; Cosby, L.A.; Sartorelli, A.C. 1984: 2,3-Dimethyl-1,4-naphthoquinone derivatives as bioreductive alkylating agents with cross-linking potential. Journal of Medicinal Chemistry 27(6): 813-815
Sheetz, M.P.; Casaly, J. 1980: 2,3-Diphosphoglycerate and ATP dissociate erythrocyte membrane skeletons. Journal of Biological Chemistry 255(20): 9955-9960
Ricci, G.; Castaldi, G.; Masotti, M.; Lupi, G.; Bonetti, D. 1984: 2,3-Diphosphoglycerate and P50 after exercise. Acta Haematologica 71(6): 410-411
Rörth, M.; Brahe, N.E. 1971: 2,3-Diphosphoglycerate and creatine in the red cell during human pregnancy. Scandinavian Journal of Clinical and Laboratory Investigation 28(3): 271-276
Zachara, B.; Lewandowski, J. 1973: 2,3-Diphosphoglycerate and hemoglobin function in blood preserved at 4 centigrades C. Acta Haematologica Polonica 4(3): 269-277
Schull, W.J.; Goldsmith, R.I.; Clench, J.; Ferrell, R.E.; Barton, S.A.; Rothhammer, F. 1981: 2,3-Diphosphoglycerate and night vision. Aviation Space and Environmental Medicine 52(1): 41-44
De Verdier, C.H.; Garby, L. 1972: 2,3-Diphosphoglycerate and respiratory function of hemoglobin. Biochimie 54(5): 613-617
Benesch, R.E.; Maeda, N.; Benesch, R. 1972: 2,3-Diphosphoglycerate and the relative affinity of adult and fetal hemoglobin for oxygen and carbon monoxide. Biochimica et Biophysica Acta 257(1): 178-182
Alberti, K.G.; Emerson, P.M.; Darley, J.H.; Hockaday, T.D. 1972: 2,3-Diphosphoglycerate and tissue oxygenation in uncontrolled diabetes mellitus. Lancet 2(7774): 391-395
Schettini, F.; Mautone, A.; De Lucia, I. 1974: 2,3-Diphosphoglycerate content of erythrocytes in the thalassemic trait. Bollettino della Societa Italiana di Biologia Sperimentale 50(4): 215-218
Gabarashvili, L.V.; Kvirikadze, N.K.; Iosava, K.V.; Dzhaparidze, M.O. 1984: 2,3-Diphosphoglycerate content of the erythrocytes in patients with acute myocardial infarct. Laboratornoe Delo 11: 656-658
Standl, E.; Kolb, H.J. 1973: 2,3-Diphosphoglycerate fluctuations in erythrocytes reflecting pronounced blood glucose variation. In-vivo and in-vitro studies in normal, diabetic and hypoglycaemic subjects. Diabetologia 9(6): 461-466
Rorth, M. 1970: 2,3-Diphosphoglycerate in erythrocytes. Biochemistry and physiology. Ugeskrift for Laeger 132(16): 727-729
Rorth, M. 1970: 2,3-Diphosphoglycerate in erythrocytes. Pathophysiology. Ugeskrift for Laeger 132(16): 730-733
Anonymous 1970: 2,3-Diphosphoglycerate in trauma. In: Energy metabolism in trauma. Ciba Foundation symposium 1970: 39-41
Schweizer, O.; Howland, W.S. 1974: 2,3-Diphosphoglycerate levels in CPD-preserved bank blood. Anesthesia and Analgesia 53(4): 516-519
Hicks, J.L.; Will, D.H. 1972: 2,3-Diphosphoglycerate levels of erythrocytes in hypoxia-induced bovine pulmonary hypertension. Journal of the American Osteopathic Association 72(2): 172-173
Arese, P.; Bosia, A.; Pescarmona, G.P.; Till, U. 1974: 2,3-Diphosphoglycerate synthesis by human white ghosts. Febs Letters 49(1): 33-36
Magnan de Bornier, B.; Vallet, B.; Callis, A.; Arnavielhe-Bony, M.; Thomas, N. 1973: 2,3-Diphosphoglycerate variation in human erythrocytes in relation to hematocrit. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences. Serie D: Sciences Naturelles 276(6): 1071-1074
Hawes, E.M.; Gorecki, D.J.; Johnson, D.D. 1973: 2,3-Disubstituted 1,6-naphthyridines as potential diuretic agents. Journal of Medicinal Chemistry 16(7): 849-853
Hoshi, M.; Kishimoto, Y.; Hignite, C. 1973: 2,3-Erythro-dihydroxyhexacosanoic acid and homologs: isolation from yeast cerebrin phosphate and determination of their structures. Journal of Lipid Research 14(4): 406-414
Syllm-Rapoport, I.; Jacobasch, G.; Roigas, H.; Rapoport, S. 1965: 2,3-PGase deficiency as a possible cause of increased ATP-content. Folia Haematologica 83(4): 363-365
Pifferi, G.; Consonni, P.; Banfi, S.; Diena, A. 1969: 2,3-benzoxazines. IX. Synthesis and central nervous system depressant activity of some 3,6- and 3,7-disubstituted 1H-3,4-dihydro-2,3-benzoxazines. Journal of Medicinal Chemistry 12(2): 261-266
Hayashi, N. 1983: 2,3-bisphosphoglycerate metabolism in human erythrocytes. Influence of erythrocyte aging. Nihon Ika Daigaku Zasshi 50(4): 516-525
Rutstein, D.D.; Veech, R.L.; Nickerson, R.J.; Felver, M.E.; Vernon, A.A.; Needham, L.L.; Kishore, P.; Thacker, S.B. 1983: 2,3-butanediol: an unusual metabolite in the serum of severely alcoholic men during acute intoxication. Lancet 2(8349): 534-537
Strumilo, S.A.; Taranda, N.I.; Vinogradov, V.V. 1984: 2,3-butanedione desensitization of bovine adrenal 2-oxoglutarate dehydrogenase to adenosine-5'-diphosphate. Biomedica Biochimica Acta 43(2): 237-240
Tallentire, A.; Schiller, N.L.; Powers, E.L. 1968: 2,3-butanedione, an electron-stabilizing compound, as a modifier of sensitivy of Bacillus megaterium spores to X-rays. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 14(5): 397-402
Karle, I.L.; Daly, J.W.; Witkop, B. 1969: 2,3-cis-3,4-trans-3,4-dihydroxy-L-proline: mass spectrometry and X-ray analysis. Science 164(3886): 1401-1402
Manchanda, A.H.; Nabney, J.; Young, D.W. 1968: 2,3-dehydro-o-(2-pyrrolylcarbonyl)virgiline, an alkaloid from Readea membranaceae Gillespie (Rubiaceae). Journal of the Chemical Society. Perkin Transactions 1 5: 615-616
Okuda, S.; Suzuki, N. 1983: 2,3-diamino-2,3-dideoxy-D-glucofuranurono-6,3-lactam from the hydrolysate of Pseudomonas aeruginosa P14 lipopolysaccharide. Biochemical Journal 215(3): 597-604
Bailey, D.M.; Siggins, J.E.; De Grazia, C.G. 1971: 2,3-diarylphthalimidines. Journal of Medicinal Chemistry 14(3): 240-241
Winterfeld, K.; Wildersohn, M. 1970: 2,3-dichloro- and 2,3,7-trichloro-5-aza-quinoxaline. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft 303(1): 44-48
Walker, D.; Hiebert, J.D. 1967: 2,3-dichloro-5,6-dicyanobenzoquinone and its reactions. Chemical Reviews 67(2): 153-195
Young, I.G.; Jackman, I.M.; Gibson, F. 1967: 2,3-dihydro-2,3-dihydroxybenzoic acid: an intermediate in the biosynthesis of 2,3-dihydroxybenzoic acid. Biochimica et Biophysica Acta 148(1): 313-315
Misiti, D.; Rimatori, V. 1970: 2,3-dihydro-2-phenyl-1,4-benzoxazepin-5(4H)-one from the reaction of the flavanone with hydrazoic acid. a reappraisal. Tetrahedron Letters 12: 947-950
Davis, L.; Agnew, M.N.; Effland, R.C.; Klein, J.T.; Kitzen, J.M.; Schwenkler, M.A. 1983: 2,3-dihydro-3-(1-pyrryl)spiro[benzofuran-2,4'-piperidine]s and 2,3-dihydro-3-(1-pyrryl)spiro[benzofuran-2,3'-pyrrolidine]s: novel antihypertensive agents. Journal of Medicinal Chemistry 26(10): 1505-1510
Bonola, G.; Sianesi, E. 1970: 2,3-dihydro-4 (H)-quinazolinone derivatives. Journal of Medicinal Chemistry 13(2): 329-332
Wright, G.C.; Schwan, T.J.; Goldenberg, M.M.; White, R.E. 1983: 2,3-dihydro-4H-1-benzopyran-4-one O-carbamoyloximes, a series of gastric antisecretory agents. Journal of Pharmaceutical Sciences 72(11): 1361-1363
O'Brien, I.G.; Cox, G.B.; Gibson, F. 1969: 2,3-dihydroxy-N-benzoylserine: chemical synthesis and comparison with the natural product. Biochimica et Biophysica Acta 177(2): 321-328
Korth, H. 1970: 2,3-dihydroxybenzoic acid and its amino acid derivatives in the culture medium of Klebsiella oxytoca. Archiv für Mikrobiologie 70(3): 297-302
Valenta, J.R.; Hoover, J.R.; Pagano, J.F. 1966: 2,3-dihydroxymethylquinoxaline-1,4-di-N-oxide, a new metabolite of 2,3-dimethylquinoxaline-1,4-di-N-oxide active against gram-negative bacteria. Antimicrobial Agents and ChemoTherapy 6: 453-456
Fairweather, L.J.; Walker, J.; Flenley, D.C. 1974: 2,3-diphosphoglycerate concentrations and the dissociation of oxyhaemoglobin in ventilatory failure. Clinical Science and Molecular Medicine 47(6): 577-588
Haidas, S.; Labie, D.; Kaplan, J.C. 1971: 2,3-diphosphoglycerate content and oxygen affinity as a function of red cell age in normal individuals. Blood 38(4): 463-467
Böswart, J.; Kuta, I.; Lisý, Z.; Kostiuk, P. 1980: 2,3-diphosphoglycerate during exercise. European Journal of Applied Physiology and Occupational Physiology 43(3): 193-199
Shafer, A.W.; Tague, L.L.; Welch, M.H.; Guenter, C.A. 1971: 2,3-diphosphoglycerate in red cells stored in acid-citrate-dextrose and citrate-phosphate-dextrose: implications regarding delivery of oxygen. Journal of Laboratory and Clinical Medicine 77(3): 430-437
Schröter, W. 1970: 2,3-diphosphoglycerate metabolism and 2,3-diphosphoglycerate mutase deficiency in erythrocytes. Blut 20(5): 311-316
Schröter, W.; Bodemann, H. 1968: 2,3-diphosphoglycerate metabolism and cation permeability in erythrocytes of the newborn. Monatsschrift für Kinderheilkunde 116(6): 412
Duhm, J.; Deuticke, B.; Gerlach, E. 1969: 2,3-diphosphoglycerate metabolism and glycolysis in human erythrocytes. Influence of sulfate, tetrathionate and disulfite. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 350(8): 1008-1016
Schröter, W.; Winter, P. 1967: 2,3-diphosphoglycerate metabolism in the erythrocytes of the newborn and of adults. Klinische Wochenschrift 45(5): 255-261
Chen, S.H.; Anderson, J.E.; Giblett, E.R. 1971: 2,3-diphosphoglycerate mutase: its demonstration by electrophoresis and the detection of a genetic variant. Biochemical Genetics 5(5): 481-486
Rose, Z.B.; Liebowitz, J. 1970: 2,3-diphosphoglycerate phosphatase from human erythrocytes. General properties and activation by anions. Journal of Biological Chemistry 245(12): 3232-3241
Gallagher, P.J. 1971: 2,3-diphosphoglyercate in acute asthma. Journal of Clinical Pathology 24(6): 518-519
Corey, E.J.; Ortiz de Montellano, P.R.; Lin, K.; Dean, P.D. 1967: 2,3-iminosqualene, a potent inhibitor of the enzymic cyclization of 2,3-oxidosqualene to sterols. Journal of the American Chemical Society 89(11): 2797-2798
Cory, E.J.; Russey, W.E.; Ortiz de Montellano, P.R. 1966: 2,3-oxidosqualene, an intermediate in the biological synthesis of sterols from squalene. Journal of the American Chemical Society 88(20): 4750-4751
Podack, E.R.; Seubert, W. 1972: 2,3-trans-Hexenoyl-CoA-reductase and 2,3-trans-decenoyl-CoA-reductase as components of microsomal, malonyl-CoA-dependent or mitochondrial acetyl CoA dependent chain prolongation of fatty acids. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 353(10): 1557
Tedeschi, H.; Horn, H.W. 1967: 2,4 dinitrophenol and the permeability of mitochondria. Biochemical and Biophysical Research Communications 28(5): 752-757
Koenig, M.; Savage, C.A. 1970: 2,4,4'-Trichloro-2'-hydroxydiphenyl ether, a new antimicrobicum, and its importance in the washing of hospital laundry. South African Medical Journal 44(29): 848-851
Lloyd, J.W.; Thomas, J.A.; Mawhinney, M.G. 1973: 2,4,5 T and the metabolism of testosterone-1,2- 3 H 2 by mouse prostate glands. Archives of Environmental Health 26(4): 217-220
Kling, D.; Becker, M.M.; Kruth, H.S.; Gamble, W. 1984: 2,4,5,2',4',5'-Hexachlorobiphenyl-lipoprotein (LDL, HDL, VLDL) interaction and induced lipidosis in cultured skin fibroblasts. Environmental Research 34(1): 87-102
Sipes, I.G.; Slocumb, M.L.; Perry, D.F.; Carter, D.E. 1982: 2,4,5,2',4',5'-Hexachlorobiphenyl: distribution, metabolism, and excretion in the dog and the monkey. Toxicology and Applied Pharmacology 65(2): 264-272
Anonymous 1982: 2,4,5- and 2,4,6-Trimethylaniline and their hydrochlorides. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 27: 177-188
Kjellstrom, T. 1980: 2,4,5-T and cancer. New Zealand Medical Journal 91(658): 318-319
Courtney, K.D.; Ebron, M.T. 1981: 2,4,5-T effects on cardiac and serum lactic dehydrogenase (LDH) and creatine kinase (CK) isozymes. I. Maternal enzyme activities and isozyme profiles. Archives of Environmental Contamination and Toxicology 10(5): 571-581
Courtney, K.D.; Ebron, M.T. 1981: 2,4,5-T effects on cardiac and serum lactic dehydrogenase (LDH) and creatine kinase (CK) isozymes. II. Neonatal enzyme activities and isozyme profiles. Archives of Environmental Contamination and Toxicology 10(5): 583-595
Thomas, H.F. 1980: 2,4,5-T use and congenital malformation rates in Hungary. Lancet 2(8187): 214-215
Honchar, P.A.; Halperin, W.E. 1981: 2,4,5-T, trichlorophenol, and soft tissue sarcoma. Lancet 1(8214): 268-269
Waters, J.A.; Creveling, C.R.; Witkop, B. 1974: 2,4,5-Trimethylpyrrole-3-carboxylic acid esters of various alkaloids. Journal of Medicinal Chemistry 17(5): 488-491
Ting, L.P.; Wang, J.H. 1981: 2,4,6-Trinitrobenzenesulfonate labels an essential amino group near the bound phosphate at the catalytic site of mitochondrial F1-ATPase. Biochemical and Biophysical Research Communications 101(3): 934-938
Goyal, A.; Katiyar, S.S. 1995: 2,4,6-Trinitrobenzenesulphonic acid as a probe for lysine at the active site of dextransucrase from Leuconostoc mesenteroides NRRL B-512F. Biochemistry and Molecular Biology International 36(3): 639-647
Karamova, N.S.; Mynina, I.I.; Garaeva, G.G.; Ivanchenko, O.B.; Il'inskaia, O.N. 1995: 2,4,6-trinitrotoluene and 2,4-diamino-6-nitrotoluene: the absence of recA-dependent mutagenesis?. Genetika 31(5): 617-621
Zinner, G.; Böse, D. 1970: 2,4,6-trioxo- and 2,4-dioxo-1,5-diazabicyclo-3,3,0-octane. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft 303(3): 218-224
Corbascio, A.N.; Crantz, P.L.; Handschumacher, G.M. 1968: 2,4,7-triamino-O-tolyl-pteridine (WR 3090) and propranolol. a comparative study of their anti-arrhythmic actions. Proceedings of the Western Pharmacology Society 11: 107-109
Ghosh, D.; Mukherjee, M. 1967: 2,4-Bis(arylamino)-5-methylpyrimidines as antimicrobial agents. Journal of Medicinal Chemistry 10(5): 974-975
Ghosh, D. 1966: 2,4-Bis(arylamino)pyrimidines as antimicrobial agents. Journal of Medicinal Chemistry 9(3): 423-424
Sano, S. 1966: 2,4-Bis-(beta-hydroxypropionic acid) deuteroporphyrinogen IX, a possible intermediate between coproporphyrinogen 3 and protoporphyrin IX. Journal of Biological Chemistry 241(22): 5276-5283
Korte, C.; Jalal, S.M. 1982: 2,4-D induced clastogenicity and elevated rates of sister chromatid exchanges in cultured human lymphocytes. Journal of Heredity 73(3): 224-226
Roth, B.; Strelitz, J.Z.; Rauckman, B.S. 1980: 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 2. C-Alkylation of pyrimidines with Mannich bases and application to the synthesis of trimethoprim and analogues. Journal of Medicinal Chemistry 23(4): 379-384
Rauckman, B.S.; Roth, B. 1980: 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 3. C-Benzylation of aminopyridines with phenolic Mannich bases. Synthesis of 1- and 3-deaza analogues of trimethoprim. Journal of Medicinal Chemistry 23(4): 384-391
Roth, B.; Aig, E.; Rauckman, B.S.; Strelitz, J.Z.; Phillips, A.P.; Ferone, R.; Bushby, S.R.; Sigel, C.W. 1981: 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 5. 3',5'-Dimethoxy-4'-substituted-benzyl analogues of trimethoprim. Journal of Medicinal Chemistry 24(8): 933-941
Roth, B.; Aig, E.; Lane, K.; Rauckman, B.S. 1980: 2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 4. 6-Substituted trimethoprim derivatives from phenolic Mannich intermediates. Application to the synthesis of trimethoprim and 3,5-dialkylbenzyl analogues. Journal of Medicinal Chemistry 23(5): 535-541
De Haën, C.; Nist, B.J.; Hansen, R.S.; Johnson, D.G.; Thompson, W.J. 1984: 2,4-Diamino-5-cyano-6-halopyridines: a new class of cyclic AMP phosphodiesterase inhibitors with therapeutic potential. Biochemical Pharmacology 33(13): 2109-2113
Rosowsky, A.; Mota, C.E.; Queener, S.F.; Waltham, M.; Ercikan-Abali, E.; Bertino, J.R. 1995: 2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii. Journal of Medicinal Chemistry 38(5): 745-752
Khaled, M.A.; Morin, R.D.; Benington, F.; Daugherty, J.P. 1984: 2,4-Diamino-6-(bis-2-chloroethyl)aminomethyl pteridine. a new potent anticancer drug. Cancer ChemoTherapy and Pharmacology 13(2): 73-74
DeGraw, J.I.; Brown, V.H.; Kiskiuk, R.L.; Gaumont, Y. 1971: 2,4-Diamino-6-arylethylpteridines as Streptococcus faecium growth inhibitors. Journal of Medicinal Chemistry 14(9): 866-867
Misch, C.E. 1981: An improved design and technique for mucosal inserts. Implantologist 2(2): 39-47
Rosowsky, A.; Forsch, R.A.; Queener, S.F. 1995: 2,4-Diaminopyrido[3,2-d]pyrimidine inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii. Journal of Medicinal Chemistry 38(14): 2615-2620
Rosowsky, A.; Chaykovsky, M.; Chen, K.K.; Lin, M.; Modest, E.J. 1973: 2,4-Diaminothieno(2,3-d)pyrimidines as antifolates and antimalarials. 1. Synthesis of 2,4-diamino-5,6,7,8-tetrahydrothianaphthena(2,3-d)pyrimidines and related compounds. Journal of Medicinal Chemistry 16(3): 185-188
Chaykovsky, M.; Lin, M.; Rosowsky, A.; Modest, E.J. 1973: 2,4-Diaminothieno(2,3-d)pyrimidines as antifolates and antimalarials. 2. Synthesis of 2,4-diaminopyrido(4',3':4,5)thieno(2,3-d)pyrimidines and 2,4-diamino-8H-thiopyrano(4',3':4,5)thieno(2,3-d)pyrimidines. Journal of Medicinal Chemistry 16(3): 188-191
Rosowsky, A.; Chen, K.K.; Lin, M. 1973: 2,4-Diaminothieno(2,3-d)pyrimidines as antifolates and antimalarials. 3. Synthesis of 5,6-disubstituted derivatives and related tetracyclic analogs. Journal of Medicinal Chemistry 16(3): 191-194
Khalatkar, A.S.; Bhargava, Y.R. 1982: 2,4-Dichlorophenoxyacetic acid--a new environmental mutagen. Mutation Research 103(2): 111-114
Kimbrough, R.D.; Gaines, T.B.; Linder, R.E. 1974: 2,4-Dichlorophenyl-p-nitrophenyl ether (TOK): effects on the lung maturation of rat fetus. Archives of Environmental Health 28(6): 316-320
Dommes, V.; Kunau, W.H. 1984: 2,4-Dienoyl coenzyme a reductases from bovine liver and Escherichia coli. Comparison of properties. Journal of Biological Chemistry 259(3): 1781-1788
Hester, J.B.; Rudzik, A.D.; VonVoigtlander, P. 1980: 2,4-Dihydro-6-phenyl-1H-s-triazolo[4,3-a][1,4]benzoidiazepin-1-ones with antianxiety and antidepressant activity. Journal of Medicinal Chemistry 23(4): 402-405
Allen, G.R.; De Vries, V.G.; Greenblatt, E.N.; Littell, R.; McEvoy, F.J.; Moran, D.B. 1973: 2,4-Dimethyl derivatives of 5-methoxy-3-indolylethylamines. new 5-oxygenated tryptamines. Journal of Medicinal Chemistry 16(8): 949-951
Anonymous 1969: 2,4-Dimethylheptanoic acid: a "glycogenic" fatty acid. Nutrition Reviews 27(2): 61-63
Lobanova, N.D.; Rudyk, B.I. 1981: 2,4-Dinitrochlorobenzene test in rheumatoid arthritis. Voprosy Revmatizma 3: 40-41
Ganote, C.E.; Grinwald, P.M.; Nayler, W.G. 1984: 2,4-Dinitrophenol (DNP)-induced injury in calcium-free hearts. Journal of Molecular and Cellular Cardiology 16(6): 547-557
Jarett, L.; Hendler, R.W. 1967: 2,4-Dinitrophenol and azide as inhibitors of protein and ribonucleic acid synthesis in anaerobic yeast. Biochemistry 6(6): 1693-1703
Bonewell, G.W.; Rossini, L. 1969: 2,4-Dinitrophenol inhibition of chymotrypsin, trypsin and pronase digestion of bovine serum albumin. Italian Journal of Biochemistry 18(6): 457-474
El-Guindy, M.M.; Neder, A.C.; Gomes, C.B. 1981: 2,4-Dinitrophenol--mechanism of action. Cellular and Molecular Biology Including Cyto-Enzymology 27(5): 399-402
Eriksson, C.J.; Lindros, K.O.; Forsander, O.A. 1974: 2,4-Dinitrophenol-induced increase in ethanol and acetaldehyde oxidation in the perfused rat liver. Biochemical Pharmacology 23(15): 2193-2195
Antonov, V.F.; Afanas'ev, A.L. 1972: 2,4-Dinitrophenol-induced transport of K+, H+ and Cl- ions in rat liver mitochondria. Biofizika 17(5): 817-823
Lawrence, D.A.; Spiegelberg, H.L.; Weigle, W.O. 1973: 2,4-Dinitrophenyl receptors on mouse thymus and spleen cells. Journal of Experimental Medicine 137(2): 470-482
Morris, P.W.; McSwine, R. 1983: 2,4-Dinitrophenylhydrazone formation at the aldehyde derived by periodate cleavage of alpha-amanitin. International Journal of Peptide and Protein Research 22(5): 597-602
Ghosh, D.; Mukherjee, M. 1968: 2,4-bis(aryloxy)pyrimidines as antimierobial agents. Journal of Medicinal Chemistry 11(6): 1237-1238
Dewey, V.C.; Kidder, G.W. 1969: 2,4-diamino-5, 6,7,8-tetrahydroquinazoline, a new pteridine antagonist. Biochemical and Biophysical Research Communications 34(4): 495-502
Then, R.L. 1980: 2,4-diamino-5-(3,5-dimethoxy-4-substituted)-benzyl-pyrimidines as ligands in affinity chromatography of bacterial dihydrofolate reductases. Biochimica et Biophysica Acta 614(1): 25-30
Stuart, A.; Paterson, T.; Roth, B.; Aig, E. 1983: 2,4-diamino-5-benzylpyrimidines and analogues as antibacterial agents. 6. a one-step synthesis of new trimethoprim derivatives and activity analysis by molecular modeling. Journal of Medicinal Chemistry 26(5): 667-673
Catto, A.; Lo Verde, G.; Luca, C.; Graziani, G.; Nardi, D.; Casadio, S. 1982: 2,4-diamino-6-piperidinyl- and 6-piperazinylpyrimidine 3-oxides, new analogs of minoxidil. Bollettino Chimico Farmaceutico 121(1): 16-26
Hampshire, J.; Hebborn, P.; Triggle, A.M.; Triggle, D.J. 1966: 2,4-diamino-6-substituted-5-(4-carbethoxyphenylazo) pyrimidines as irreversible inhibitors of folic acid reductase. Journal of Pharmaceutical Sciences 55(4): 453-454
Evarts, R.P.; Brown, C.A. 1980: 2,4-diaminoanisole sulfate: early effect on thyroid gland morphology and late effect on glandular tissue of Fischer 344 rats. Journal of the National Cancer Institute 65(1): 197-204
Evarts, R.P.; Brown, C.A. 1981: 2,4-diaminoanisole-induced thyroid pigmentation in rats inhibited by m-phenylenediamine. Toxicology Letters 8(4-5): 257-264
Somack, R.; Costilow, R.N. 1973: 2,4-diaminopentanoic acid C 4 dehydrogenase. Purification and properties of the protein. Journal of Biological Chemistry 248(2): 385-388
Roth, B. 1969: 2,4-diaminopyrimidines. the cyclization of 6-phenacylthio and related derivatives to thieno[2,3-d]pyrimidines and thiazolo[3,2-c]pyrimidines. Journal of Medicinal Chemistry 12(2): 227-232
Dyer, J.K.; Costilow, R.N. 1970: 2,4-diaminovaleric acid: an intermediate in the anaerobic oxidation of ornithine by Clostridium sticklandii. Journal of Bacteriology 101(1): 77-83
Berwick, P. 1970: 2,4-dichlorophenoxyacetic acid poisoning in man. Some interesting clinical and laboratory findings. JAMA 214(6): 1114-1117
Pacák, J.; Podesva, J.; Cerný, M. 1970: 2,4-dideoxy-2,4-difluoro-D-glucose. Chemistry and Industry 28: 929
Pietta, P.G.; Cavallo, P.; Marshall, G.R. 1971: 2,4-dimethoxybenzyl as a protecting group for glutamine and asparagine in peptide synthesis. Journal of Organic Chemistry 36(25): 3966-3970
Schwan, T.J.; Tieckelmann, B.; Holland, J.F.; Bryant, B. 1965: 2,4-dimethyl-5-hydroxymethylpyrimidine, a pyridoxol antagonist. Journal of Medicinal Chemistry 8(6): 750-753
Cobb, L.M.; Connors, T.A.; Elson, L.A.; Khan, A.H.; Mitchley, B.C.; Ross, W.C.; Whisson, M.E. 1969: 2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256. Biochemical Pharmacology 18(6): 1519-1527
Christodoulou, C.; Reese, C.B. 1982: 2,4-dinitrobenzyl - a terminal phosphate protecting group in the phosphotriester approach to oligonucleotide synthesis. Nucleic Acids Symposium Series 11: 33-36
Cirelli, A.; D'Amato, C.; Lanzalone, C.M. 1974: 2,4-dinitrochlorobenzene (DNCB) in the study of delayed hypersensitivity in some infectious diseases. Bollettino della Societa Italiana di Biologia Sperimentale 50(15): 1157-1162
Fedotov, V.P.; Lesnitskiĭ, A.I.; Logunov, V.P.; Manuĭlova, L.A.; Zheliaz, E.V. 1981: 2,4-dinitrochlorobenzene skin test as an index of the primary cellular immunological response in skin diseases and syphilis. Vestnik dermatologii i venerologii 1981(10): 7-12
Tiukhtin, N.S.; Berlova, Z.D.; Veselova, L.P. 1980: 2,4-dinitrochlorobenzene skin test in the differential diagnosis of pulmonary tuberculosis. Problemy Tuberkuleza 8: 71-73
Katyare, S.S.; Fatterpaker, P.; Sreenivasan, A. 1970: 2,4-dinitrophenol and oxidation of substrates by rat liver mitochondria. Indian Journal of Biochemistry 7(1): 1-8
Omachi, A.; Scott, C.B.; Glader, B.E. 1968: 2,4-dinitrophenol inhibition of P32 release from human red cells. Experientia 24(3): 244-245
Barnett, D.; Welbourne, T.C. 1982: 2,4-dinitrophenol stimulation of renal ammoniagenesis. Biochimica et Biophysica Acta 715(2): 215-221
Duncan, C.J.; Greenaway, H.C.; Smith, J.L. 1980: 2,4-dinitrophenol, lysosomal breakdown and rapid myofilament degradation in vertebrate skeletal muscle. Naunyn-Schmiedeberg's Archives of Pharmacology 315(1): 77-82
Wolfrom, M.L.; Bhat, H.B. 1967: 2,4-dinitrophenyl as N-blocking group in pyrimidine nucleoside synthesis with 2-amino sugars. Journal of Organic Chemistry 32(9): 2757-2759
Yamada, H.; Yamada, A.; Hollander, V.P. 1970: 2,4-dinitrophenyl-hapten specific hemolytic plaque-in-gel formation by mouse myeloma (MOPC-315) cells. Journal of Immunology 104(1): 251-255
Woodson, A.L. 1971: 2,4-dinitrophenylhydrazine: a sensitive quantitative reagent for determining microgram quantities of prednisone. Journal of Pharmaceutical Sciences 60(10): 1538-1542
Libert, R.; De Hertogh, R. 1971: 2,4-dinitrophenylhydrazones of 17-ketosteroids. Description of some physicochemical properties and their practical application in quantitative measurements. Analytical Biochemistry 40(2): 351-358
Montgomery, J.A.; Hewson, K. 1972: 2,5-Anhydro-1-deoxy-1-((6-methylthio)purin-9-yl)-D-allitol. Journal of Medicinal Chemistry 15(5): 571
Meyer, R.B.; Stone, T.E.; Jesthi, P.K. 1984: 2,5-Anhydro-1-deoxy-1-phosphono-D-altritol, an isosteric analogue of alpha-D-ribofuranose 1-phosphate. Journal of Medicinal Chemistry 27(8): 1095-1098
Middleditch, B.S.; Hines, H.B.; Bastian, F.O.; Middleditch, P.R. 1980: 2,5-Di-t-amyl-p-benzoquinone: an antioxidant encountered during the analysis of human tissues. Biomedical Mass Spectrometry 7(3): 105-108
Poochikian, G.K.; Kelley, J.A. 1981: 2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone II: Isolation and characterization of degradation products. Journal of Pharmaceutical Sciences 70(2): 162-167
Eisner, T.; Hendry, L.B.; Peakall, D.B.; Meinwald, J. 1971: 2,5-Dichlorophenol (from ingested herbicide?) in defensive secretion of grasshopper. Science 172(3980): 277-278
Idänpään-Heikkilä, J.E.; McIsaac, W.M. 1970: 2,5-Dimethoxy-4-methyl-amphetamine--tissue distribution and neurochemical action. Biochemical Pharmacology 19(3): 935-937
Wallach, M.B.; Friedman, E.; Gershon, S. 1972: 2,5-Dimethoxy-4-methylamphetamine (DOM), a neuropharmacological examination. Journal of Pharmacology and Experimental Therapeutics 182(1): 145-154
Snyder, S.H.; Faillace, L.; Hollister, L. 1968: 2,5-Dimethoxy-4-methylamphetamine: new hallucinogenic drug. Science 159(3822): 1492
Brewster, K.; Pinder, R.M. 1971: 2,5-Dimethoxy-4-methylphenylalanine. Journal of Medicinal Chemistry 14(17): 650-651
Singh, K.P.; Kannan, K.; Goel, S.K.; Pandya, K.P.; Shanker, R. 1983: 2,5-Hexane diol induced thymic atrophy and lymphocytotoxicity in rats. Industrial Health 21(4): 235-242
Sulkowski, T.S.; Wille, M.A.; Mascitti, A.; Diebold, J.L. 1967: 2,5-benzodiazocines and intermediates. Journal of Organic Chemistry 32(7): 2180-2184
Hladiková, D.; Sobĕslavský, C.; Havelka, S. 1967: 2,5-dehydroxyphenylpyruvic acid in the urine of patients with rheumatoid arthritis. Reumatologia 5(1): 57-59
Mazzone, G.; Bonina, F.; Puglisi, G.; Panico, A.M.; Arrigo Reina, R. 1984: 2,5-diaryl-substituted 1,3,4-oxadiazoles: synthesis and preliminary pharmacological investigation. Il Farmaco; Edizione Scientifica 39(5): 414-420
Fernández-Tomé, M.P.; Madroñero, R.; Del Rio, J.; Vega, S. 1972: 2,5-dihydro-1,2,4-benzothiadiazepine 1,1-dioxides. Synthesis and pharmacological evaluation. Journal of Medicinal Chemistry 15(9): 887-890
Genghof, D.S. 1970: 2,5-dihydrophenylalanine as an inhibitor of microbial growth. Canadian Journal of Microbiology 16(6): 545-547
Bernaerts, M.; De Ley, J. 1971: 2,5-diketogluconate formation by Chromobacterium. Antonie van Leeuwenhoek 37(2): 185-195
Snyder, S.H.; Faillace, L.; Hollister, L. 1967: 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug. Science 158(3801): 669-670
Faillace, L.A.; Synder, S.H.; Weingartner, H. 1970: 2,5-dimethoxy-4-methylamphetamine: clinical evaluation of a new hallucinogenic drug. Journal of Nervous and Mental Disease 150(2): 119-126
LeBlanc, G.D.; Babineau, L.M. 1972: 2,5-dimethoxybenzoquinone, 3,4-dimethyl-8-hydroxyisocoumarin, and eburicoic acid isolated from Lenzites thermophila Falck-75. Canadian Journal of Microbiology 18(2): 261-263
Morrison, G.C.; Waite, R.O.; Caro, A.N.; Shavel, J. 1967: 2,5-dimethylindolo [2,3-f] morphan. Journal of Organic Chemistry 32(11): 3691-3693
Boshoff, C. 1966: The first drink. Sa Nursing Journal. Sa Verplegingstydskrif 33(2): 13-14 Passim
Pirsig, W.; Pentz, S. 1994: 2,500 years of nosebleeding in art. Rhinology 32(3): 151-157
Knapp, M. 1969: 2,526 Arizona nurses spoke up. Arizona Nurse 22(1): 18-21
Kumaravel, G.; Gandour, R.D.; Fronczek, F.R. 1995: 2,6,6-Trimethyl-2-oxo-1,3-dioxa-6-azonia-2-phosphocyclooctane iodide. Acta Crystallographica. Section C Crystal Structure Communications 51: 1919-1921
Moore, G.G.; Swingle, K.F. 1982: 2,6-Di-tert-butyl-4-(2'-thenoyl)phenol(R-830): a novel nonsteroidal anti-inflammatory agent with antioxidant properties. Agents and Actions 12(5-6): 674-683
Cignarella, G.; Testa, E. 1968: 2,6-Dialkylpiperazines. IV. 1-Propionyl-4-substituted cis-2,6-dimethylpiperazines structurally related to the analgetic 8-acyl-3,8-diazabicyclo[3.2.1]octanes. Journal of Medicinal Chemistry 11(3): 592-594
Cignarella, G.; Testa, E. 1968: 2,6-Dialkylpiperazines. V. Synthesis of 2,6-alkylpiperazine derivatives structurally related to cinnarazine. Journal of Medicinal Chemistry 11(3): 612-615
Bailey, K.; Thomas, B.H.; Vézina, M.; Whitehouse, L.W.; Zeitz, W.; Solomonraj, G. 1983: 2,6-Diamino-5-hydroxy-3-(phenylazo)pyridine, a novel metabolite of phenazopyridine in the rat. Drug Metabolism and Disposition: the Biological Fate of Chemicals 11(3): 277-278
Baum, T.; Eckfeld, D.K.; Metz, N.; Dinish, J.L.; Rowles, G.; Van Pelt, R.; Shropshire, A.T.; Fernandez, S.P.; Gluckman, M.I.; Bruce, W.F. 1969: 2,6-Dichlorobenzylidene amino guanidine acetate (Wy-8678). a new hypotensive agent. Experientia 25(10): 1066-1067
Ernsberger, P.; Li, P.; Smyth, D.D. 1995: 2,6-Dimethyl clonidine: alpha 2-adrenoceptor or I1-imidazoline receptor agonist?. Annals of the new York Academy of Sciences 763: 96-99
Greter, J.; Lindstedt, S.; Steen, G. 1983: 2,6-Dimethyloctanedioic acid--a metabolite of phytanic acid in Refsum's disease. Clinical Chemistry 29(3): 434-437
Finkelstein, J.; Romano, J.A. 1968: 2,8-Substituted 4-methyl-1(2H)-phthalazinones. Journal of Medicinal Chemistry 11(2): 398-399
Chien, P.L.; Cheng, C.C. 1966: 2,8-bis(substituted amino)phenothiazine 5,5-dioxides. Journal of Medicinal Chemistry 9(6): 960-962
Witten, F.R.; Morgan, J.W.; Foster, J.G.; Glenn, J.F. 1983: 2,8-dihydroxyadenine urolithiasis: review of the literature and report of a case in the United States. Journal of Urology 130(5): 938-942
Mohindru, A.; Fisher, J.M.; Rabinovitz, M. 1983: 2,9-Dimethyl-1,10-phenanthroline (neocuproine): a potent, copper-dependent cytotoxin with anti-tumor activity. Biochemical Pharmacology 32(23): 3627-3632
Anonymous 1983: 2- and 3-Methylfluoranthenes. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 32: 399-404
Heiss, W.D. 1983: 2- and 3-dimensional isotope technics for the regional measurement of blood supply and metabolism. Wiener Medizinische Wochenschrift 133(9): 220-223
Gajewski, T.; Tylicki, C. 1967: 2- and multistage surgical procedures on the intestines. Polski Przeglad Chirurgiczny 39(12): 1277-1280
Fontanella, L. 1970: 2-(1-hydantoin) propionic acids. Il Farmaco; Edizione Scientifica 25(7): 542-561
Görlitzer, K.; Dehne, A.; Engler, E. 1983: 2-(1H-Tetrazol-5-yl)-4,5-dihydroindeno[1,2-b]pyran-4-one. Archiv der Pharmazie 316(3): 264-270
Srivastava, V.K.; Satsangi, R.K.; Kishore, K. 1982: 2-(2'-Hydroxyphenyl)-4-aryl-1,5-benzodiazepines as CNS active agents. Arzneimittel-Forschung 32(12): 1512-1514
Atkinson, D.C.; Godfrey, K.E.; Jordan, B.J.; Leach, E.C.; Meek, B.; Nichols, J.D.; Saville, J.F. 1974: 2-(2,4-dichlorophenoxy) phenylacetic acid (fenclofenac): one of a novel series of anti-inflammatory compounds with low ulcerogenic potential. Journal of Pharmacy and Pharmacology 26(5): 357-358
Lambein, F. 1973: 2-(2-Cyano-ethyl)-isoxazolin-5-one from sweet peas. Archives Internationales de Physiologie et de Biochimie 81(2): 380
Pruss, T.P.; Hidalgo, J. 1965: 2-(2-Dimethylaminoethoxy)-3-(4-methoxybenzyl)-4H-pyrido[1,2-a]pyrimidin-4-one HC1 (CL-1182C), a potent histamine releaser. Journal of Pharmaceutical Sciences 54(6): 888-890
Carissimi, M.; Picciòla, G.; Ravenna, F.; Carenini, G.; Gentili, P. 1980: 2-(2-Thienyl)morpholines with CNS activity. Il Farmaco; Edizione Scientifica 35(10): 812-825
Hashimoto, M.; Hattori, K. 1967: 2-(2-heptenyl)-3-methyl-4-quinolinol from a Pseudomonas. Chemical and Pharmaceutical Bulletin 15(5): 718-720
Burckhalter, J.H.; Dixon, W.D.; Black, M.L.; Westland, R.D.; Werbel, L.M.; DeWald, H.A.; Dice, J.R.; Rodney, G.; Kaump, D.H. 1967: 2-(2-pyridyl)-1,2-diarylalkanols as hypocholesteremic agents. Journal of Medicinal Chemistry 10(4): 565-575
Sjaastad, O.; Stensrud, P. 1971: 2-(2.6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155 or Catapresan) as a prophylactic remedy against migraine. Acta Neurologica Scandinavica 47(1): 120-122
Sam, J.; Shafik, R.M. 1969: 2-(3-biphenylyl)ethylamines: Potential cardiovascular agents. Journal of Pharmaceutical Sciences 58(8): 952-955
Sam, J.; Aparajithan, K.; Shafik, R. 1968: 2-(4-Biphenylyl)ethylamines: potential cardiovascular and CNS agents. Journal of Pharmaceutical Sciences 57(4): 564-568
Herndon, C.S.; Hartman, F.C. 1984: 2-(4-Bromoacetamido)anilino-2-deoxypentitol 1,5-bisphosphate, a new affinity label for ribulose bisphosphate carboxylase/oxygenase from Rhodospirillum rubrum. Determination of reaction parameters and characterization of an active site peptide. Journal of Biological Chemistry 259(5): 3102-3110
Boselli, G. 1974: 2-(4-Isobutylphenyl)-propionic acid in the topical treatment of venous and lymphatic inflammations. Comparative study and statistical evaluation of results. Minerva Medica 65(73): 3829-3834
Viara, M. 1973: 2-(4-Isobutylphenyl)-propionic acid in the treatment of rheumatic diseases: clinical effects and tolerance. Minerva Medica 64(47): 2513-2514
Hepworth, W.; Newbould, B.B.; Platt, D.S.; Stacey, G.J. 1969: 2-(4-chlorophenyl)thiazol-4-ylacetic acid('Myalex'): a new compound with anti-inflammatory,, analgesic and antipyretic activity. Nature 221(5180): 582-583
Burger, A.; Bernabé, M.; Collins, P.W. 1970: 2-(4-imidazolyl)cyclopropylamine. Journal of Medicinal Chemistry 13(1): 33-35
Nabil Aboul-Enein, M.; el-Difrawy, S.M. 1973: 2-(4-methoxybenzyl)-pyrrolidines as potent amoebicides. Pharmaceutica Acta Helvetiae 48(6): 405-411
Mallevais, M.L.; Delacourte, A.; Lesieur, I.; Lesieur, D.; Cazin, M.; Brunet, C.; Luyckx, M. 1984: 2-(4-methyl-1-piperazinylmethyl) acrylophenone dihydrochloride: a new antimicrotubular drug. Biochimie 66(6): 477-482
Lalezari, I.; Ghabgharan, F.; Maghsoudi, R. 1971: 2-(5-nitro-2-thienyl)cinchoninic acids. Journal of Medicinal Chemistry 14(5): 465
Ghali, N.I.; Venton, D.L.; Hung, S.C.; Le Breton, G.C. 1983: 2-(6-carboxyhexyl)cyclopentanone hexylhydrazone. a potent and time-dependent inhibitor of platelet aggregation. Journal of Medicinal Chemistry 26(7): 1056-1060
Le Breton, G.C.; Hung, S.C.; Ghali, N.I.; Venton, D.L. 1984: 2-(6-carboxyhexyl)cyclopentanone hexylhydrazone: a potent inhibitor of the blood platelet cyclo-oxygenase. Prostaglandins 27(4): 543-551
Novinson, T.; Springer, R.H.; O'Brien, D.E.; Scholten, M.B.; Miller, J.P.; Robins, R.K. 1982: 2-(Alkylthio)-1,2,4-triazolo[1,5-a]pyrimidines as adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitors with potential as new cardiovascular agents. Journal of Medicinal Chemistry 25(4): 420-426
Yoshida, A.; Hayashi, T.; Takeda, N.; Oida, S.; Ohki, E. 1981: 2-(Alkylthio)penem-3-carboxylic acids. III. Synthesis of 6-ethylpenems. Chemical and Pharmaceutical Bulletin 29(7): 1854-1861
Naito, S.I.; Shimizu, S. 1973: 2-(Aminoethanesulfonylamino)thiazole and related compounds. I. Stability, absorption, excretion, and some pharmacological activities. Journal of Pharmaceutical Sciences 62(1): 82-87
Stokker, G.E.; Deana, A.A.; deSolms, S.J.; Schultz, E.M.; Smith, R.L.; Cragoe, E.J.; Baer, J.E.; Ludden, C.T.; Russo, H.F.; Scriabine, A.; Sweet, C.S.; Watson, L.S. 1980: 2-(Aminomethyl)phenols, a new class of saluretic agents. 1. Effects of nuclear substitution. Journal of Medicinal Chemistry 23(12): 1414-1427
Stokker, G.E.; Smith, R.L.; Cragoe, E.J.; Ludden, C.T.; Russo, H.F.; Sweet, C.S.; Watson, L.S. 1981: 2-(Aminomethyl)phenols, a new class of saluretic agents. 2. Synthesis and pharmacological properties of the 5-aza isostere of 2-(aminomethyl)-4-(1,1-dimethylethyl)-6-iodophenol. Journal of Medicinal Chemistry 24(1): 115-117
Stokker, G.E.; Deana, A.A.; deSolms, S.J.; Schultz, E.M.; Smith, R.L.; Cragoe, E.J.; Baer, J.E.; Russo, H.F.; Watson, L.S. 1981: 2-(Aminomethyl)phenols, a new class of saluretic agents. 3. Effects of functional group reorientation and modification. Journal of Medicinal Chemistry 24(9): 1063-1067
Stokker, G.E.; Deana, A.A.; deSolms, S.J.; Schultz, E.M.; Smith, R.L.; Cragoe, E.J.; Baer, J.E.; Russo, H.F.; Watson, L.S. 1982: 2-(Aminomethyl)phenols, a new class of saluretic agents. 4. Effects of oxygen and/or nitrogen substitution. Journal of Medicinal Chemistry 25(6): 735-742
Stokker, G.E.; Schultz, E.M.; Smith, R.L.; Cragoe, E.J.; Russo, H.F.; Watson, L.S.; Ludden, C.T.; Sweet, C.S. 1983: 2-(Aminomethyl)phenols, a new class of saluretic agents. 6. Effects of N,O-spiroannulation and subsequent quaternization. Journal of Medicinal Chemistry 26(4): 585-590
Brancaccio, G.; Larizza, A.; Lettieri, G.; Monforte, P. 1981: 2-(Arylmethyl)arylacetic acids as potential antiinflammatory agents. Journal of Medicinal Chemistry 24(8): 998-1000
Rafael, J. 1980: 2-(Dimethylaminostyryl)-1-ethylpyridinium iodide: a fluorescent probe of energetic conditions in brown-adipose-tissue mitochondria. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 361(3): 437-444
Stangier, P.; Palcic, M.M.; Bundle, D.R. 1995: 2-(Dimethyloctylsilyl) ethyl lactoside: a versatile intermediate for chemical and enzymic ganglioside synthesis. Carbohydrate Research 267(1): 153-159
Wollweber, H.; Kölling, H.; Niemers, E.; Widdig, A.; Andrews, P.; Schulz, H.P.; Thomas, H. 1984: 2-(Guanidino)-anilides and related compounds. Synthesis and anthelmintic effect. 3. Anthelmintics. Arzneimittel-Forschung 34(5): 531-542
Von Angerer, E.; Prekajac, J. 1983: 2-(Hydroxyphenyl)indoles: a new class of mammary tumor inhibiting compounds. Journal of Medicinal Chemistry 26(1): 113-116
Franke, A.; Frickel, F.F.; Gries, J.; Lenke, D.; Schlecker, R.; Thieme, P.D. 1981: 2-(Isoxazolylethenyl)phenoxypropanolamines: a new class of beta-receptor antagonists with antihypertensive activity. Journal of Medicinal Chemistry 24(12): 1460-1464
Novelli, A.; Barrio, J.R.; Huidobro, H. 1969: 2-(N,N-Dialkylamino)ethyl esters of alpha-(3-pyridyl)mandelic acids. Synthesis and pharmacological evaluation. Journal of Medicinal Chemistry 12(5): 851-854
Werbel, L.M.; Elslager, E.F.; Phillips, A.A.; Worth, D.F.; Islip, P.J.; Neville, M.C. 1969: 2-(alkyl- and arylamino)-5-nitrothiazole derivatives with antiamebic, antitrichomonal, and antimalarial properties. Journal of Medicinal Chemistry 12(3): 521-524
Freist, W.; Helbig, R.; Cramer, F. 1970: 2-(alpha-pyridyl)ethanol as phosphate protecting group. Chemische Berichte 103(4): 1032-1036
Duncan, W.G.; Henry, D.W. 1969: 2-(omega-aminoalkyl)-4-5-butyl-6-phenylphenols as antimalarial agents. Journal of Medicinal Chemistry 12(4): 711-712
McInerney, E.F.; Kupchik, E.J. 1967: 2-(purin-6-yl)-2-thiopseudourea hydrochloride. Journal of Medicinal Chemistry 10(4): 741
Picart, N.; Lanoy, M.; Courtoy, P. 1970: 2-1 and 1-1 auricular flutter attack and Wolff-Parkinson-White syndrome. Acta Cardiologica 25(1): 77-85
Kaul, R.; Kiefer, G.; Erhardt, S.; Hempel, B. 1980: 2-14C-1-(2'-deoxy-beta-D-ribofuranosyl)-5-ethyluracil: synthesis and biotransformation in rats. Journal of Pharmaceutical Sciences 69(5): 531-534
Kaul, R.; Hempel, B.; Kiefer, G. 1982: 2-14C-1-Allyl-3,5-diethyl-6-chlorouracil I: Synthesis, absorption in human skin, excretion, distribution, and metabolism in rats and rabbits. Journal of Pharmaceutical Sciences 71(8): 893-896
Kaul, R.; Hempel, B.; Kiefer, G. 1982: 2-14C-1-Allyl-3,5-diethyl-6-chlorouracil II: Isolation and structures of the major sulfur-free and three minor sulfur-containing metabolites and mechanism of biotransformation. Journal of Pharmaceutical Sciences 71(8): 897-900
Bonati, M.; Latini, R.; Marzi, E.; Cantoni, R.; Belvedere, G. 1980: 2-14C]caffeine metabolism in control and 3-methylcholanthrene induced rat liver microsomes by high pressure liquid chromatography. Toxicology Letters 7(1): 1-7
Hooper, M.; Spedding, M.; Sweetman, A.J.; Weetman, D.F. 1974: 2-2' pyridylisatogen tosylate: an antagonist of the inhibitory effects of ATP on smooth muscle. British Journal of Pharmacology 50(3): 458P-459P
Sarkar, S.R.; Singh, L.R.; Banerji, R.; Chaudhuri, B.N. 1980: 2-3 Diphosphoglycerate, adenosine triphosphate and reduced glutathione content of rat blood in acute hypoxia. Indian Journal of Experimental Biology 18(1): 79-80
Höltl, G. 1972: 2-3 resection of a single kidney. Zeitschrift für Urologie und Nephrologie 65(1): 27-31
Cristea, E.; Dinu, V.; Dinu, I.; Mihăilescu, I.; Boghianu, L. 1981: 2-4-Dichloro-phenoxy-acetic acid interactions with the detoxification hepatic systems. Physiologie 18(3): 199-203
Rice, A.P.; Roberts, W.K.; Kerr, I.M. 1984: 2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication. Journal of Virology 50(1): 220-228
Affabris, E.; Romeo, G.; Belardelli, F.; Jemma, C.; Mechti, N.; Gresser, I.; Rossi, G.B. 1983: 2-5A synthetase activity does not increase in interferon-resistant Friend leukemia cell variants treated with alpha/beta interferon despite the presence of high-affinity interferon receptor sites. Virology 125(2): 508-512
Silverman, R.H.; Cayley, P.J.; Wreschner, D.H.; Knight, M.; Gilbert, C.S.; Brown, R.E.; Kerr, I.M. 1981: 2-5A(pppA2'p5'A2'p5'A) in interferon-treated encephalomyocarditis virus-infected mouse L-cells. Texas Reports on Biology and Medicine 41: 479-486
Derevitskaya, V.A.; Likhosherstov, L.M.; Schennikov, V.A.; Kochetkov, N.K. 1971: 2-Acetamido-3,6-anhydro-2-deoxy-D-hexoses: products of the alkaline degradation of 2-acetamido-2-deoxy-D-hexoses. Carbohydrate Research 20(2): 285-291
Fumo, A. 1966: 2-Acetamido-4-(5-nitro-2-furyl)-thiazole in the therapy of oral moniliasis of the newborn. Minerva Ginecologica 18(9): 476-479
Knirel, Y.A.; Paramonov, N.A.; Vinogradov, E.V.; Kochetkov, N.K.; Sidorczyk, Z.; Zych, K. 1994: 2-Acetamido-4-O-[(S)-1-carboxyethyl]-2-deoxy-D-glucose: a new natural isomer of N-acetylmuramic acid from the O-specific polysaccharide of Proteus penneri 35. Carbohydrate Research 259(1): C1-C3
Horton, H.R.; Young, G. 1969: 2-Acetoxy-5-nitrobenzyl chloride. A regent designed to introduce a reporter group near the active site of chymotrypsin. Biochimica et Biophysica Acta 194(1): 272-278
Glazer, R.I.; Nutter, R.C.; Glass, L.E.; Menger, F.M. 1974: 2-Acetylaminofluorene and N-hydroxy-2-acetylaminofluorene inhibition of incorporation of orotic acid-5-3H into nuclear ribosomal and heterogeneous RNA in normal and regenerating liver. Cancer Research 34(10): 2451-2458
Aström, A.; dePierre, J.W. 1982: 2-Acetylaminofluorene induces forms of cytochrome P-450 active in its own metabolism. Carcinogenesis 3(6): 711-713
Landegent, J.E.; Jasen in de Wal, N.; Baan, R.A.; Hoeijmakers, J.H.; Van der Ploeg, M. 1984: 2-Acetylaminofluorene-modified probes for the indirect hybridocytochemical detection of specific nucleic acid sequences. Experimental Cell Research 153(1): 61-72
Shepard, C.C.; Klayman, D.L.; Scovill, J.P.; Morrison, N.E. 1984: 2-Acetylpyridine thiosemicarbazones and Mycobacterium leprae. International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 52(1): 7-9
Scovill, J.P.; Klayman, D.L.; Franchino, C.F. 1982: 2-Acetylpyridine thiosemicarbazones. 4. Complexes with transition metals as antimalarial and antileukemic agents. Journal of Medicinal Chemistry 25(10): 1261-1264
Klayman, D.L.; Scovill, J.P.; Mason, C.J.; Bartosevich, J.F.; Bruce, J.; Lin, A.J. 1983: 2-Acetylpyridine thiosemicarbazones. 6.2-Acetylpyridine and 2-butyrylpyridine thiosemicarbazones as antileukemic agents. Arzneimittel-Forschung 33(7): 909-912
Klayman, D.L.; Scovill, J.P.; Bruce, J.; Bartosevich, J.F. 1984: 2-Acetylpyridine thiosemicarbazones. 8. Derivatives of 1-acetylisoquinoline as potential antimalarial agents. Journal of Medicinal Chemistry 27(1): 84-87
Scovill, J.P.; Klayman, D.L.; Lambros, C.; Childs, G.E.; Notsch, J.D. 1984: 2-Acetylpyridine thiosemicarbazones. 9. Derivatives of 2-acetylpyridine 1-oxide as potential antimalarial agents. Journal of Medicinal Chemistry 27(1): 87-91
Hiltmann, R.; Hoffmeister, F.; Niemers, E.; Schlichting, U.; Wollweber, H. 1974: 2-Acylaminopyridine derivatives with morphine agonistic and morphine antagonistic effects. Arzneimittel-Forschung 24(4): 584-600
Letellier, P.R.; Nawar, W.W. 1972: 2-Alkylcyclobutanones from the radiolysis of triglycerides. Lipids 7(1): 75-76
Maguire, M.H.; Nobbs, D.M.; Einstein, R.; Middleton, J.C. 1971: 2-Alkylthioadenosines, specific coronary vasodilators. Journal of Medicinal Chemistry 14(5): 415-420
Shikita, M.; Sato, F. 1969: 2-Alphahydroxysteroid dehydrogenase and reductive metabolism of progesterone in mammalian cell cultures. Archives of Biochemistry and Biophysics 133(2): 336-344
Rodríguez de Lores Arn; Alberici de Canal, M.; De Robertis, E. 1971: 2-Amine 4-pentenoic acid (allylglycine): a proposed tool for the study of GABA mediated systems. International Journal of Neuroscience 2(3): 137-144
Brill, E.; Radomski, J.L. 1965: 2-Amino-1,4-naphthoquinone-N4, 2-naphthylimine. a photo-oxidation product of 2-aminonaphthalene. Experientia 21(7): 368-369
Jann, B.; Jann, K.; Beyaert, G.O. 1973: 2-Amino-2,6-dideoxy-d-glucose (D-quinovosamine): a constituent of the lipopolysaccharides of Vibrio cholerae. European Journal of Biochemistry 37(3): 531-534
Wolfrom, M.L.; Winkley, M.W. 1966: 2-Amino-2-deoxy-D-xylose and 2-amino-2-deoxy-D-ribose and their 1-thioglycofuranosides. Journal of Organic Chemistry 31(4): 1169-1173
Reistad, R. 1974: 2-Amino-2-deoxyguluronic acid: a constituent of the cell wall of Halococcus sp., strain 24. Carbohydrate Research 36(2): 420-423
Romanowska, E.; Reinhold, V. 1973: 2-Amino-2-deoxyhexuronic acid: a constituent of Shigella sonnei phase i lipopolysaccharide. European Journal of Biochemistry 36(1): 160-166
Klayman, D.L.; Maul, J.; Milne, G.W. 1967: 2-Amino-2-thiazoline. 3. the differing behavior of phenylisothiocyanate and phenylisocyanate toward 2-amino-2-thiazoline. Tetrahedron Letters 3: 281-284
Eiden, F.; Felbermeir, G.; Buchborn, H. 1983: 2-Amino-3-hydroxy-1-thiochromones. Archiv der Pharmazie 316(11): 921-933
Eiden, F.; Dölcher, D. 1972: 2-Amino-3-hydroxychromone. 39. 4-pyrones. Archiv der Pharmazie 305(9): 698-701
Pinder, R.M.; Brimblecombe, R.W.; Green, D.M. 1969: 2-Amino-3-phenyl-1,1,1-trifluoropropanes. Fluorine analogs of amphetamines. Journal of Medicinal Chemistry 12(2): 322-324
Sindelar, R.D.; Mott, J.; Barfknecht, C.F.; Arneric, S.P.; Flynn, J.R.; Long, J.P.; Bhatnagar, R.K. 1982: 2-Amino-4,7-dimethoxyindan derivatives: synthesis and assessment of dopaminergic and cardiovascular actions. Journal of Medicinal Chemistry 25(7): 858-864
Lanthorn, T.H.; Ganong, A.H.; Cotman, C.W. 1984: 2-Amino-4-phosphonobutyrate selectively blocks mossy fiber-CA3 responses in guinea pig but not rat hippocampus. Brain Research 290(1): 174-178
Taylor, J.B.; Lewis, J.W.; Jacklin, M. 1970: 2-Amino-5,6-dihydroxyindan-2-carboxylic acid. a potential hypotensive agent. Journal of Medicinal Chemistry 13(6): 1226-1227
Kreutzberger, A.; Schücker, R. 1971: 2-Amino-5,7-dipropyl-s-triazolo(1,5-a)pyrimidine. 6. Condensations with hydrazine-N,N'-dicarbonic acid-diamidine. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft 304(11): 856-863
Berkelhammer, G.; Asato, G. 1968: 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3, 4-thiadiazole: a new antimicrobial agent. Science 162(3858): 1146
Redin, G.S.; Kuck, N.A.; Forbes, M. 1968: 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole, a new antimicrobial age. VI. Antibacterial efficacy in mice and in vitro. Antimicrobial Agents and ChemoTherapy 8: 534-537
Carvajal, S.; Pidacks, S.; Steinmann, H.; Maxon, H.; Wozniak, A. 1968: 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole, a new antimicrobial agent. 8. Antiamoebic activity in vivo of the hydrochloride salt. Antimicrobial Agents and ChemoTherapy 8: 541-544
Burden, E.J.; Racette, E. 1968: 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole, a new antimicrobial agent. IX. Action against hemoflagellate infections in laboratory animals. Antimicrobial Agents and ChemoTherapy 8: 545-547
Layton, H.W.; Bachmann, H.J.; Kemp, G.A.; Gale, G.O.; Kiser, J.S. 1968: 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole, a new antimicrobial agent. V. Therapy of an experimental Salmonella choleraesuis infection iswine. Antimicrobial Agents and ChemoTherapy 8: 528-533
Burden, E.J.; Schumacher, E.; Kelly, M. 1968: 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole, a new antimicrobial agent. VII. Action against subcutaneous Trichomonas vaginalis infections in mice. Antimicrobial Agents and ChemoTherapy 8: 538-540
Bachmann, H.J.; Shirk, R.J.; Layton, H.W.; Kemp, G.A. 1968: 2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole, a new antimicrobial agents. IV. Activity in mice and chicks. Antimicrobial Agents and ChemoTherapy 8: 524-527
Davies, J.; Francis, A.A.; Jones, A.W.; Watkins, J.C. 1981: 2-Amino-5-phosphonovalerate (2APV), a potent and selective antagonist of amino acid-induced and synaptic excitation. Neuroscience Letters 21(1): 77-81
Lee, C.J.; Serif, G.S. 1968: 2-Amino-6-(methylthio)caproic acid, a methionine homolog and precursor of progoitrin. Biochimica et Biophysica Acta 165(3): 569-571
Guérémy, C.; Audiau, F.; Uzan, A.; Le Fur, G.; Léger, J.M.; Carpy, A. 1982: 2-Amino-6-chloro-4-(N-methylpiperazino)pyrimidines, inhibitors of spiroperidol binding. Journal of Medicinal Chemistry 25(12): 1459-1465
Kreutzberger, A.; Schücker, R. 1973: 2-Amino-imidazoles through reduction of 2,2'-azoimidazoles. 11. Condensation with hydrazine-N,N'-dicarbonic acid diamines. Archiv der Pharmazie 306(2): 139-151
Meldrum, B.; Wardley-Smit, B.; Halsey, M.; Rostain, J.C. 1983: 2-Amino-phosphonoheptanoic acid protects against the high pressure neurological syndrome. European Journal of Pharmacology 87(4): 501-502
Nagaswa, H.T.; Elberling, J.A.; Shirota, F.N. 1973: 2-Aminoadamantane-2-carboxylic acid, a rigid, achiral, tricyclic alpha-amino acid with transport inhibitory properties. Journal of Medicinal Chemistry 16(7): 823-826
Mattalia, G.; Marchetti, E. 1971: 2-Aminoalkyl-4,5-diphenyloxazoles with anti-inflammatory and analgesic activities. Il Farmaco; Edizione Scientifica 26(6): 512-519
Anonymous 1982: 2-Aminoanthraquinone. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 27: 191-198
Hashimoto, Y.; Iijima, H.; Shudo, K.; Itoh, M. 1984: 2-Aminodipyrido[1,2-a:3',2'-d]imidazole-porphyrin(Fe) derivatives as sequence specific DNA cleaving reagents. Nucleic Acids Symposium Series 15: 157-159
Wolfensberger, M.; Felix, D.; Cuénod, M. 1982: 2-Aminoethanol as a possible neuromodulator in the pigeon optic tectum. Neuroscience Letters 32(1): 53-58
Lacoste, A.M.; Dumora, C.; Cassaigne, A. 1984: 2-Aminoethylphosphonate: pyruvate aminotransferase from Pseudomonas aeruginosa. Progress in Clinical and Biological Research 144b: 321-327
Alhadeff, J.A.; Daves, G.D. 1971: 2-Aminoethylphosphonic acid: distribution in human tissues. Biochimica et Biophysica Acta 244(1): 211-213
Pinder, R.M.; Butcher, B.H.; Buxton, D.A.; Howells, D.J. 1971: 2-Aminoindan-2-carboxylic acids. Potential tyrosine hydroxylase inhibitors. Journal of Medicinal Chemistry 14(9): 892-893
Solomons, E.; Sam, J. 1973: 2-Aminoindans of pharmacological interest. Journal of Medicinal Chemistry 16(12): 1330-1333
Schuart, J.; Müller, H.K.; Wendt, U. 1974: 2-Aminooxazoles and 2-imino-oxazolines. 2. Preparation, properties and spectroscopic data on 2-imino-3-alkyl aryl-4,5-diphenyloxazolines. Die Pharmazie 29(2): 100-102
Schuart, J.; Müller, H.K. 1973: 2-Aminooxazoles and 2-iminooxazolines. 1. Reaction of racemic alpha-methylaminopropiophenone using cyanobromide. Die Pharmazie 28(7): 438-439
Schuart, J.; Müller, H.K. 1974: 2-Aminooxazoles and 2-iminooxazolines. 3. Selected examples of a homolog series of 3 substituted 2-imino-4-methyl-5-phenyloxazolines. Die Pharmazie 29(3): 170-172
Schuart, J.; Wendt, U.; Müller, H.K. 1974: 2-Aminooxazoles and 2-iminooxazolines. 4. Products of acetylation. Die Pharmazie 29(12): 763-765
Itano, H.A.; Yamada, S. 1972: 2-Aminophenanthroimidazole, fluorescent product of the reaction of phenanthrenequinone with arginine. Analytical Biochemistry 48(2): 483-490
Ronen, A. 1980: 2-Aminopurine. Mutation Research 75(1): 1-47
Vigier, P.R.; Marcovich, H. 1973: 2-Aminopurine induced mutations in T4 bacteriophage. Molecular and General Genetics: Mgg 127(4): 317-325
Maenhaut-Michel, G.; Caillet-Fauquet, P. 1982: 2-Aminopurine, analog of adenine, induces a nonmutagenic repair mechanism acting upon UV lesions of double-stranded DNA in E. coli. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 176(3): 406-410
Yokoyama, N.; Ritter, B.; Neubert, A.D. 1982: 2-Arylpyrazolo[4,3-c]quinolin-3-ones: novel agonist, partial agonist, and antagonist of benzodiazepines. Journal of Medicinal Chemistry 25(4): 337-339
Borne, R.F.; Clark, C.R.; Holbrook, J.M. 1973: 2-Azabicyclo(2.2.2)octane derivatives as conformational analogs of local anesthetics. Journal of Medicinal Chemistry 16(7): 853-856
Benjamin, L.E.; Fryer, R.I.; Gilman, N.W.; Trybulski, E.J. 1983: 2-Benzazepines. 2. Thiazolo[5,4-d][2]benzazepines. Journal of Medicinal Chemistry 26(1): 100-103
Trybulski, E.J.; Benjamin, L.; Vitone, S.; Walser, A.; Fryer, R.I. 1983: 2-Benzazepines. 4. [1,2,3]Triazolo[4,5-d][2]benzazepines and dibenzo[c,f][1,2,3]triazolo[3,4-a]azepines: synthesis and evaluation as central nervous system agents. Journal of Medicinal Chemistry 26(3): 367-372
Lalloz, L.; Loppinet, V.; Coudert, G.; Guillaumet, G.; Loubinoux, B.; Labrid, C.; Beaughard, M.; Dureng, G.; Lamar, J.C. 1981: 2-Benzodioxinylaminoethanols: a new class of beta-adrenergic blocking and antihypertensive agents. Journal of Medicinal Chemistry 24(8): 994-998
Gerhards, E.; Kolb, K.H. 1965: 2-Benzolsulfonamido-5(beta-methoxy-ethoxy)-pyrimidine (Glycodiazine). II. Metabolism of 2-benzolsulfonamido-5(beta-hydroxy-ethoxy)-pyrimidine, a blood sugar reducing metabolite of glycodiazine in man. Arzneimittel-Forschung 15(12): 1375-1379
Brewster, K.; Pinder, R.M. 1972: 2-Benzylaziridines. Cyclic analogs of amphetamines. Journal of Medicinal Chemistry 15(10): 1078-1079
Flückiger, E.; Wagner, H.R. 1968: 2-Br-alpha-ergokryptin: influence on fertility and lactation in the rat. Experientia 24(11): 1130-1131
Alaimo, R.J.; Goldenberg, M.M. 1982: 2-Bromo-1-hydroxyquinolizinium bromide substituted anilinium salts: a new class of anti-inflammatory agents. Journal of Pharmaceutical Sciences 71(11): 1299-1300
Clements, P.R.; Wallace, J.C.; Keech, D.B. 1981: 2-Bromoacetyl-SCoA. Methods in Enzymology 72: 578-579
Fraij, B.; Hartman, F.C. 1982: 2-Bromoacetylaminopentitol 1,5-bisphosphate as an affinity label for ribulose bisphosphate carboxylase/oxygenase from Rhodospirillum rubrum. Journal of Biological Chemistry 257(7): 3501-3505
Dahmén, J.; Frejd, T.; Magnusson, G.; Noori, G.; Carlström, A.S. 1984: 2-Bromoethyl glycosides in glycoside synthesis: preparation of glycoproteins containing alpha-L-Fuc-(1----2)-D-Gal and beta-D-Gal-(1----4)-D-GlcNAc. Carbohydrate Research 125(2): 237-245
Raaka, B.M.; Lowenstein, J.M. 1981: 2-Bromooctanoate. Methods in Enzymology 72: 559-577
Nantka-Namirski, P.; Ozdowska, Z. 1972: 2-Carbethoxyindole derivatives. I. Synthesis of 8-alkoxy- and 8,9-benzo-3H-pyridazino(4,5-b) indol-4-ones. Acta Poloniae Pharmaceutica 29(1): 9-15
Nantka-Namirski, P.; Ozdowska, Z. 1972: 2-Carbethoxyindole derivatives. II. Synthesis of 8-benzyloxy-3H-pirydazino(4,5-b)indole-4-one. Acta Poloniae Pharmaceutica 29(1): 16-19
Keese, W.; Khalaf, H.; Grambow, D.; Grundke, G.; Rimpler, M. 1985: 2-Chloro-1-methylpyridinium iodide. a suitable reagent for peptide synthesis. Biological Chemistry Hoppe-Seyler 366(12): 1093-1095
Zaucha, J.M.; Ciesielski, D.; Grieb, P.; Hellmann, A. 1994: 2-Chloro-2'-deoxyadenosine (2-CdA) treatment in a patient with Waldenström's macroglobulinaemia complicated by severe neutrocytopenia. Archivum Immunologiae et Therapiae Experimentalis 42(1): 35-37
Liliemark, J.; Juliusson, G. 1994: 2-Chloro-2'-deoxyadenosine--clinical, biochemical and pharmacokinetic considerations. Archivum Immunologiae et Therapiae Experimentalis 42(1): 7-10
Henkel, E.; Morich, S.; Henkel, R. 1984: 2-Chloro-4-nitrophenyl-beta-D-maltoheptaoside: a new substrate for the determination of alpha-amylase in serum and urine. Journal of Clinical Chemistry and Clinical Biochemistry 22(7): 489-495
Delarge, J.; Fernandez, D.; Lapière, C.L. 1967: 2-Chloro-5-nitropyridine, the first compound in the synthesis of pyridine-5-carboxy-2-sulfonic acid and pyridine-2,5-disulfonic acid. Journal de Pharmacie de Belgique 22(5): 213-219
Weuffen, W.; Kramer, A.; Höppe, H.; Witzleb, W. 1982: 2-Chloro-6-methyl-4-benzylphenol (CMB), a potential antimicrobial agent Part 1: Microbiostatic Efficiency. Die Pharmazie 37(1): 47-50
Shaw, I.C.; Graham, M.I.; McLean, A.E. 1983: 2-Chloroacetaldehyde, a metabolite of cyclophosphamide in the rat. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 13(7): 433-437
Shaw, I.C.; Graham, M.I.; McLean, A.E. 1983: 2-Chloroacetaldehyde: a metabolite of cyclophosphamide in the rat. Cancer Treatment Reviews 10(Suppl): 17-24
Niesvizky, R.; Siegel, D.; Michaeli, J. 1993: 2-Chlorodeoxyadenosine for multiple myeloma. Blood 81(3): 868-869
Zinzani, P.L.; Ricci, P.; Bendandi, M.; Tura, S. 1995: 2-Chlorodeoxyadenosine in psoriasis treatment. Annals of Oncology: Official Journal of the European Society for Medical Oncology 6(5): 509
Shealy, Y.F.; Krauth, C.A.; Laster, W.R. 1984: 2-Chloroethyl (methylsulfonyl)methanesulfonate and related (methylsulfonyl)methanesulfonates. Antineoplastic activity in vivo. Journal of Medicinal Chemistry 27(5): 664-670
Mole, J.E.; Horton, H.R. 1973: 2-Chloromethyl-4-nitrophenyl (N-carbobenzoxy)glycinate. a new reagent designed to introduce an environmentally sensitive conformational probe near the active site of papain. Biochemistry 12(26): 5278-5285
Rosenblatt, R.M. 1980: 2-Chloroprocaine combined with bupivacaine. British Journal of Anaesthesia 52(4): 466
Quistad, G.B.; Mulholland, K.M.; Jamieson, G.C. 1983: 2-Chlorotoluene metabolism by rats. Journal of Agricultural and Food Chemistry 31(6): 1158-1162
Knörig, J.M.; Otto, G. 1984: 2-Cuff technic for experimental liver transplantation in pigs. Zeitschrift für Experimentelle Chirurgie Transplantation und Kunstliche Organe: Organ der Sektion Experimentelle Chirurgie der Gesellschaft für Chirurgie der Ddr 17(4): 204-208
Von Ardenne, M.; Reitnauer, P.G.; Krüger, W. 1981: 2-Cyanoethyl urea and its derivatives as potential immunostimulants in experimental cancer therapy. Archiv für Geschwulstforschung 51(6): 485-491
Levin, L.; Meyers, G.B.; Liddane, L. 1972: 2-Cyclohexen-1-one: toxicology and study of an occupational dermal exposure. American Industrial Hygiene Association Journal 33(5): 338-342
Gilbert, B.W.; Rakowski, H. 1980: 2-D echo and LA thrombi. Circulation 61(3): 667-668
García-Fernandez, M.A.; Moreno, M.; Bañuelos, F. 1983: 2-D echo for detecting blood stasis. Circulation 67(5): 1160-1161
Falicov, R.E. 1980: 2-D echo to diagnose LA thrombi. Circulation 61(6): 1267
Kondakov, V.I.; Arsen'ev, A.S.; Pluzhnikov, K.A.; Tsetlin, V.I.; Bystrov, V.F. 1984: 2-D-NMR study of the conformation characteristics of toxin 3 from Naja naja siamensis venom. Bioorganicheskaia Khimiia 10(12): 1606-1628
Drabarek, S.; Du Vigneaud, V. 1965: 2-D-tyrosine-oxytocin and 2-D-tyrosine-deamino-oxytocin diastereoisomers of oxytocin and deamino-oxytocin. Journal of the American Chemical Society 87(17): 3974-3978
Blanc, F.; Denjean, B.; Felix, H.; Nosny, Y.; Pène, P.; Reynaud, R. 1965: 2-Dehydro-emetine administered orally in the treatment of amebiasis. 1st therapeutic trials. Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 58(3): 419-423
Félix, H.; Freyria, J.; Maillard, A. 1966: 2-Dehyro-emetine administered orally in the treatment of amebiasis. Therapeutic trials. (Apropos of 50 personal cases). Archives Francaises des Maladies de l'Appareil Digestif 55(10): 909-914
Adamson, J.; Foster, A.B.; Westwood, J.H. 1971: 2-Deoxy-2,2-difluoro-D-arabino-hexose ("2,2-difluoroglucose"). Carbohydrate Research 18(2): 345-347
Meindl, P.; Tuppy, H. 1969: 2-Deoxy-2,3-dehydrosialic acids. II. Competitive inhibition of Vibrio cholerae neuraminidase by 2-deoxy-2,3-dehydro-N-acylneuraminic acids. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 350(9): 1088-1092
Büchsel, R.; Hassels-Vischer, B.; Tauber, R.; Reutter, W. 1980: 2-Deoxy-D-galactose impairs the fucosylation of glycoproteins of rat liver and Morris hepatoma. European Journal of Biochemistry 111(2): 445-453
McCaleb, M.L.; Myers, R.D. 1982: 2-Deoxy-D-glucose and insulin modify release of norepinephrine from rat hypothalamus. American Journal of Physiology 242(5): R596-R603
McCray, M.K.; Zugerman, C. 1982: 2-Deoxy-D-glucose for herpes simplex?. Journal of the American Academy of Dermatology 6(4 Part 1): 550-551
Larue-Achagiotis, C.; Le Magnen, J. 1981: 2-Deoxy-D-glucose inhibits food intake in rats after ventromedial hypothalamic lesions. Physiology and Behavior 26(4): 613-616
Thompson, C.I.; Zagon, I.S. 1981: 2-Deoxy-D-glucose produces delayed hypophagia and conditioned taste aversion in rats. Physiology and Behavior 27(6): 1001-1004
Silverman, M.; Turner, R.J. 1982: 2-Deoxy-D-glucose transport in dog kidney. American Journal of Physiology 242(6): F711-F720
Kerr, J.S.; Reicherter, J.; Fisher, A.B. 1982: 2-Deoxy-D-glucose uptake by rat granular pneumocytes in primary culture. American Journal of Physiology 243(1): C14-C19
Shiraishi, T.; Mager, M. 1980: 2-Deoxy-D-glucose-induced hypothermia: thermoregulatory pathways in rat. American Journal of Physiology 239(3): R270-R276
Plagemann, P.G.; Wohlhueter, R.M. 1981: 2-Deoxycoformycin inhibition of intracellular phosphorylation of adenosine in Novikoff rat hepatoma cells. Biochemical Pharmacology 30(5): 417-426
Theurich, M.; Müller, C.M.; Scheich, H. 1984: 2-Deoxyglucose accumulation parallels extracellularly recorded spike activity in the avian auditory neostriatum. Brain Research 322(1): 157-161
Kellett, D.N. 1966: 2-Deoxyglucose and inflammation. Journal of Pharmacy and Pharmacology 18(3): 199-200
Suzuki, M.; O'Dea, J.D.; Suzuki, T.; Agar, N.S. 1983: 2-Deoxyglucose as a substrate for glutathione regeneration in human and ruminant red blood cells. Comparative Biochemistry and Physiology. B Comparative Biochemistry 75(2): 195-197
Mikoshiba, K.; Kohsaka, S.; Takamatsu, K.; Tsukada, Y. 1981: 2-Deoxyglucose incorporation in the cerebellum of weaver and nervous mutant mice. Journal of Neurochemistry 37(1): 186-191
Nelson, T.; Kaufman, E.E.; Sokoloff, L. 1984: 2-Deoxyglucose incorporation into rat brain glycogen during measurement of local cerebral glucose utilization by the 2-deoxyglucose method. Journal of Neurochemistry 43(4): 949-956
Eagon, R.G. 1971: 2-Deoxyglucose transportation via passive diffusion and its oxidation, not phosphorylation, to 2-deoxygluconic acid by Pseudomonas aeruginosa. Canadian Journal of Biochemistry 49(5): 606-613
Cooper, R.M.; Thurlow, G.A.; Rooney, B.J. 1984: 2-Deoxyglucose uptake and histologic changes in rat thalamus after neocortical ablations. Experimental Neurology 83(1): 134-143
Proshansky, E.; Kauer, J.S.; Stewart, W.B.; Egger, M.D. 1980: 2-Deoxyglucose uptake in the cat spinal cord during sustained and habituated activity in the plantar cushion reflex pathway. Journal of Comparative Neurology 194(3): 505-517
Cooper, R.M.; Thurlow, G.A. 1984: 2-Deoxyglucose uptake in the thalamus of awake rats after neocortical ablations. Experimental Neurology 86(2): 261-271
Scharff, T.G.; Montgomery, O.L. 1965: 2-Deoxyglucose-stimulated fermentation in yeast cells; possible relationship to cyclic fermentation in extracts. Life Sciences 4(10): 1049-1053
Udeinya, I.J.; Van Dyke, K. 1981: 2-Deoxyglucose: inhibition of parasitemia and of glucosamine incorporation into glycosylated macromolecules, in malarial parasites (Plasmodium falciparum). Pharmacology 23(3): 171-175
Jargiello, P.; Stern, M.D.; Hoffee, P. 1974: 2-Deoxyribose 5-phosphate aldolase: genetic analyses of structure. Journal of Molecular Biology 88(3): 671-691
Hoffee, P.A.; Robertson, B.C. 1969: 2-Deoxyribose gene-enzyme complex in Salmonella typhimurium: regulation of phosphodeoxyribomutase. Journal of Bacteriology 97(3): 1386-1396
Huguet, J.F.; Clement, J.P. 1973: 2-Dimensional angiocardiography or cineangiography in the diagnosis of tumors of the heart. Annales de Chirurgie Thoracique et Cardio-Vasculaire 12(3): 261-262
French, D.; Pulley, A.P.; Abdullah, M.; Linden, J.C. 1966: 2-Dimensional paper chromatography interspersed with reaction on the paper. Journal of Chromatography 24(1): 271-276
Re', O. 1974: 2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action. Current Therapeutic Research 16(11): 1238-1242
Laborit, H.; Weber, B.; Baron, C.; Delbarre, B.; Pavlovichova, H. 1965: 2-Dimethylaminoethyl-4-methyl-5-ethyl-3-pyridazone (DMAE MEP or Ag 148) cardiovascular analeptic, vasodilator and hypertensive agent. Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 6(4): 463-480
Eiden, F.; Bachmann, G. 1972: 2-Ethoxy-3-acetyl-chinoxaline. 37. Studies on 4-pyrones. Archiv der Pharmazie 305(8): 580-586
Noltemeyer, M.; Sheldrick, G.M.; Hoppe, H.U.; Zeeck, A. 1982: 2-Ethyl-5-(3-indolyl)oxazole from Streptomyces cinnamomeus discovered by chemical screening. Characterization and structure elucidation by X-ray analysis. Journal of Antibiotics 35(5): 549-555
Kornucev, D.; Babic, I. 1974: 2-Ethylpyridine derivatives with antitubercular properties. Journal of Pharmaceutical Sciences 63(3): 475-477
Baldo, J.H.; Hansen, P.E.; Shriver, J.W.; Sykes, B.D. 1983: 2-Fluoro-ATP, a fluorinated ATP analog. 19F nuclear magnetic resonance studies of the 2-fluoro-ADP . myosin subfragment-1 complex. Canadian Journal of Biochemistry and Cell Biology 61(2-3): 115-119
Liehr, J.G. 1983: 2-Fluoroestradiol. Separation of estrogenicity from carcinogenicity. Molecular Pharmacology 23(2): 278-281
Martinez, A.P.; Lee, W.W.; Goodman, L. 1968: 2-Fluoroethylamines. 3. Some alkylating agents derived from uracil. Journal of Medicinal Chemistry 11(2): 384-387
Montgomery, J.A.; Hewson, K. 1970: 2-Fluoropurine ribonucleosides. Journal of Medicinal Chemistry 13(3): 427-430
Spanò, R.; Stacchino, C.; Pettiti, A. 1981: 2-Guaiacolethanol acetylsalicilate: synthesis and some pharmacological properties. Bollettino Chimico Farmaceutico 120(12): 730-733
Klages, U.; Krauss, S.; Lingens, F. 1983: 2-Haloacid dehalogenase from a 4-chlorobenzoate-degrading Pseudomonas spec. CBS 3. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 364(5): 529-535
Marsden, P.J.; Casida, J.E. 1982: 2-Haloacrylic acids as indicators of mutagenic 2-haloacrolein intermediates in mammalian metabolism of selected promutagens and carcinogens. Journal of Agricultural and Food Chemistry 30(4): 627-631
Rosenkranz, S.; Carr, H.S.; Rosenkranz, H.S. 1974: 2-Haloethanols: mutagenicity and reactivity with DNA. Mutation Research 26(5): 367-370
Ebina, S.; Nagai, Y. 1980: 2-Halogeno-ethanols as an uncoupler of phosphorylation in rat liver mitochondria. Experientia 36(5): 537-539
Swamy, V.C.; Triggle, D.J. 1972: 2-Halogenoethylamines and the role of Ca 2+ in adrenergic -receptor activation in the rat vas deferens. European Journal of Pharmacology 19(1): 67-78
Triggle, A.M.; Triggle, D.J. 1965: 2-Halogenoethylamines as potential folic acid antagonists. I. Synthesis and biological activity of ethyl-N-[1-(2-amino-4-hydroxy-6-methyl-5-pyrimidyl)-3-(2-chloro)-propyl]-p-aminobenzoate. Journal of Pharmaceutical Sciences 54(5): 795-797
Anonymous 1968: 2-Hexanone (methyl-n-butyl ketone, n-butyl methyl ketone, propyl acetone). American Industrial Hygiene Association Journal 29(6): 618-620
Rudolph, T.; Przystal, F.; Phillips, J.P. 1967: 2-Hydrazino-8-quinolinol and derivatives. Journal of Medicinal Chemistry 10(5): 981
Levis, G.M. 1970: 2-Hydroxy fatty acid oxidases of rat kidney. Biochemical and Biophysical Research Communications 38(3): 470-477
Barfknecht, C.F.; Pirch, G. 1969: 2-Hydroxy-2-phenylethylhydrazine monoamine oxidase inhibitors. Journal of Medicinal Chemistry 12(3): 549-550
Indelicato, J.M.; Dorman, D.E.; Engel, G.L. 1981: 2-Hydroxy-3-aryl-6-methylpyrazines-fluorophores formed from the reaction of formaldehyde with cyclic enamine degradation products common to beta-lactam antibiotics with aryl glycine side chains. Journal of Pharmacy and Pharmacology 33(2): 119-121
Eiden, F.; Luft, W. 1973: 2-Hydroxychromanones-(4). 48. Studies on 4-pyrones. Archiv der Pharmazie 306(8): 634-637
Katayama, S.; Fishman, J. 1982: 2-Hydroxyestrone suppresses and 2-methoxyestrone augments the preovulatory prolactin surge in the cycling rat. Endocrinology 110(4): 1448-1450
Huggins, A.K.; Boulton, A.P. 1971: 2-Hydroxyglutarate in crustaceans. Biochemical Journal 125(4): 1141-1143
Akerfeldt, S.; Dahlén, M. 1965: 2-Hydroxyhistamine and 2-methoxyhistamine, their synthesis and certain properties. Acta Chemica Scandinavica 19(6): 1397-1400
Zinner, G.; Geister, B. 1973: 2-Hydroxylamino-adamantane. Archiv der Pharmazie 306(2): 97-101
McClelland, R.A.; Fuller, J.R.; Seaman, N.E.; Rauth, A.M.; Battistella, R. 1984: 2-Hydroxylaminoimidazoles--unstable intermediates in the reduction of 2-nitroimidazoles. Biochemical Pharmacology 33(2): 303-309
Fishman, J.; Norton, B.I.; Krey, L. 1980: 2-Hydroxylation of estrogens in the brain participates in the initiation of the preovulatory LH surge in the rat. Biochemical and Biophysical Research Communications 93(2): 471-477
Back, D.J.; Maggs, J.L.; Purba, H.S.; Newby, S.; Park, B.K. 1984: 2-Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and antipyrine. British Journal of Clinical Pharmacology 18(4): 603-607
Stoessl, A.; Rohringer, R.; Samborski, D.J. 1969: 2-Hydroxyputrescine amides as abnormal metabolites of wheat. Tetrahedron Letters 33: 2807-2810
Kitamura, S.; Kase, H.; Odakura, Y.; Iida, T.; Shirahata, K.; Nakayama, K. 1982: 2-Hydroxysagamicin: a new antibiotic produced by mutational biosynthesis of Micromonospora sagamiensis. Journal of Antibiotics 35(1): 94-97
Murray, J.S.; Hanley, T.R.; John, J.A.; Potts, W.J.; Rao, K.S. 1980: 2-Isocyanatoethyl methacrylate--an inhalation dominant lethal study in the male Sprague-Dawley rat. Drug and Chemical Toxicology 3(4): 381-392
Schachter, H.; Chan, J.Y.; Nwokoro, N.A. 1982: 2-Keto-3-deoxy-L-fuconate dehydrogenase from pork liver. Methods in Enzymology 89 Pt D: 219-225
Dahms, A.S.; Donald, A. 1982: 2-Keto-3-deoxy-d-xylonate aldolase (3-deoxy-d-pentulosonic acid aldolase). Methods in Enzymology 90 Pt E: 269-272
Meloche, H.P.; O'Connell, E.L. 1982: 2-Keto-3-deoxy-galactonate-6-phosphate aldolase from Pseudomonas saccharophila. Methods in Enzymology 90 Pt E: 263-269
Pouysségur, J.; Lagarde, A. 1973: 2-Keto-3-deoxy-gluconate transport system in E. coli K 12: map location of a structural gene and of its operator. Molecular and General Genetics: Mgg 121(2): 163-180
Kobes, R.D.; Dekker, E.E. 1969: 2-Keto-4-hydroxyglutarate aldolase of bovine liver. Purification, criteria of purity, and general properties. Journal of Biological Chemistry 244(7): 1919-1925
Kobes, R.D.; Dekker, E.E. 1971: 2-Keto-4-hydroxyglutarate aldolase of bovine liver. Schiff-base formation with 2-keto-4-hydroxyglutarate, pyruvate, and glyoxylate. Biochemistry 10(3): 388-395
Vander Jagt, D.L. 1982: 2-Ketoaldehyde dehydrogenase from rat liver. Methods in Enzymology 89 Pt D: 513-515
Daniel, J.; Dondon, L.; Danchin, A. 1983: 2-Ketobutyrate: a putative alarmone of Escherichia coli. Molecular and General Genetics: Mgg 190(3): 452-458
Skosey, J.L.; Damgaard, E. 1972: 2-Ketoglutarate oxidation by isolated rat epididymal adipose tissue and fat cells. Effects of hormones that stimulate fat cell adenylate cyclase. Endocrinology 91(5): 1233-1238
Lahav, M. 1983: 2-Mercapto-1-(beta-4-pyridethyl) benzimidazole inhibition of basal and aldosterone-stimulated sodium transport but prolongation of the transient theophylline-induced stimulation in the toad bladder. Biochemical Pharmacology 32(22): 3271-3278
Twele, R.; Kern, W.; Spiteller, G. 1983: 2-Mercapto-1-methyl-5-methylmercapto-imidazole: a new metabolite of thiamazole. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 13(11): 661-668
Westland, R.D.; Merz, M.M.; Alexander, S.M.; Newton, L.S.; Bauer, L.; Conway, T.T.; Barton, J.M.; Khullar, K.K.; Devdhar, P.B.; Grenan, M.M. 1972: 2-Mercaptoacetamidine and derivatives as antiradiation agents. Journal of Medicinal Chemistry 15(12): 1313-1321
Bauché, F.; Sabourault, D.; Giudicelli, Y.; Nordmann, J.; Nordmann, R. 1981: 2-Mercaptoacetate administration depresses the beta-oxidation pathway through an inhibition of long-chain acyl-CoA dehydrogenase activity. Biochemical Journal 196(3): 803-809
Duran, M.; Aarsen, G.; Fokkens, R.H.; Nibbering, N.M.; Cats, B.P.; de Bree, P.K.; Wadman, S.K. 1981: 2-Mercaptoethanesulfonate-cysteine disulfide excretion following the administration of 2-mercaptoethanesulfonate--a pitfall in the diagnosis of sulfite oxidase deficiency. Clinica Chimica Acta; International Journal of Clinical Chemistry 111(1): 47-53
Dev, P.K.; Pareek, B.P.; Gupta, S.M.; Goyal, P.K.; Mehta, G. 1982: 2-Mercaptopropionylglycine protection against growth-inhibiting effects in utero irradiated mice. Acta Anatomica 112(3): 249-253
Zimmer, G.; Ohlenschläger, G. 1974: 2-Mercaptopropionylglycine, a new SH-reagent for mitochondria. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 355(10): 1273
Honma, S.; Nambara, T. 1972: 2-Methoxyestrone 3-glucuronide: a new biliary metabolite in the rat. Chemical and Pharmaceutical Bulletin 20(6): 1343-1344
Anonymous 1982: 2-Methyl-1-nitroanthraquinone. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 27: 205-210
Lehnert, W.; Junker, A. 1980: 2-Methyl-3-oxovaleric acid: a characteristic metabolite in propionic acidemia. Clinica Chimica Acta; International Journal of Clinical Chemistry 104(1): 47-51
Finkelstein, J.; Chiang, E.; Lee, J. 1966: 2-Methyl-3-phenoxycyclopropylamine. Journal of Medicinal Chemistry 9(3): 440-441
Fujiwara, T.; Chiba, S. 1994: 2-Methyl-5-HT-induced vasoconstrictions mediated via alpha 1-adrenoceptors in rabbit common carotid arteries. Japanese Journal of Pharmacology 66(1): 155-157
Tura, S.; Mandelli, F.; Mazza, P.; Cimino, G.; Anselmo, A.P.; Amadori, S. 1984: 2-Methyl-9-hydroxyellipticinium acetate (ellipticinium) in the treatment of lymphomas. Preliminary results of a phase Ii study. Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 3(2): 79-82
Faleev, N.G.; Gogoleva, O.I.; Dementieva, I.S.; Zakomirdina, L.N.; Belikov, V.M. 1995: 2-Methyl-L-tryptophan is a substrate of tryptophanase. Biochemistry and Molecular Biology International 35(5): 1037-1040
Lin, T.S.; Teicher, B.A.; Sartorelli, A.C. 1980: 2-Methylanthraquinone derivatives as potential bioreductive alkylating agents. Journal of Medicinal Chemistry 23(11): 1237-1242
Shadurskiĭ, K.S.; Il'iuchenok, T.I.; Shadurskaia, S.K. 1983: 2-Methylindoles substituted in the 1st, 3d and 5th positions and the diffuse neuroendocrine APUD system. Farmakologiia i Toksikologiia 46(2): 115-120
Harada, F.; Gross, H.J.; Kimura, F.; Chang, S.H.; Nishimura, S.; RajBhandary, U.L. 1968: 2-Methylthio N6-(delta 2-isopentenyl) adenosine: a component of E. coli tyrosine transfer RNA. Biochemical and Biophysical Research Communications 33(2): 299-306
Macfarlane, D.E.; Srivastava, P.C.; Mills, D.C. 1983: 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. Journal of Clinical Investigation 71(3): 420-428
Hull, R.A.; Shankley, N.P.; Harper, E.A.; Gerkowitch, V.P.; Black, J.W. 1993: 2-Naphthalenesulphonyl L-aspartyl-(2-phenethyl)amide (2-NAP)--a selective cholecystokinin CCKA-receptor antagonist. British Journal of Pharmacology 108(3): 734-740
Mylecharane, E.J.; Raper, C. 1973: 2-Nitrilophenoxypropanolamines: -adrenoreceptor antagonism in the rat. Archives Internationales de Pharmacodynamie et de Therapie 202(1): 163-170
Raab, W. 1980: 2-Nitro-2-bromopropan-1,3-diol (bronopol) and UV-rays. Archives of Dermatological Research 269(2): 211-212
Eiden, F.; Dölcher, D. 1972: 2-Nitro-3-hydroxychromone. 38. 4-pyrones. Archiv der Pharmazie 305(9): 691-697
Perry, M.B.; Heung, L.L. 1972: 2-Nitro-4-azidophenyl glycoside affinity labelling agents. Canadian Journal of Biochemistry 50(5): 510-515
Munson, J.W. 1974: 2-Nitrophenylhydrazine: a selective reagent for colorimetric determination of carboxylic acid anhydrides and chlorides. Journal of Pharmaceutical Sciences 63(2): 252-257
Anonymous 1982: 2-Nitropropane. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 29: 331-343
Gray, W.; Bell, H. 1972: 2-O Interval as an indicator of left atrial pressure. Chest 62(5): 553-556
Ito, Y.; Oashi, Y.; Kawabe, S.; Abe, H.; Okuda, T. 1972: 2-O-(3-O-carbamoyl-D-mannosyl)-6-deoxy-L-gulose, the sugar moiety of the antibiotic YA-56. Journal of Antibiotics 25(9): 543-545
Smith, M.W.; Neidhardt, F.C. 1983: 2-Oxoacid dehydrogenase complexes of Escherichia coli: cellular amounts and patterns of synthesis. Journal of Bacteriology 156(1): 81-88
Stonard, M.D.; Parker, V.H. 1971: 2-Oxoacid dehydrogenases of rat liver mitochondria as the site of action of S-(1,2 dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-3-mercaptopropionic acid. Biochemical Pharmacology 20(9): 2417-2427
Zareba, S. 1982: 2-Phenolazoimidazole as chelating agents. II. Analytical investigations of pyrocatecholazo- and resorcinolazobenzimidazole (BIAP, BIAR, BIAREZ-beta). Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 37: 209-217
Zareba, S. 1983: 2-Phenolazoimidazoles as chelating agents. IV. Analytical studies of 2,6-dihydroxy-3-(benzoimidazolyl-2'-azo) benzoic acid (BIAREZ-gamma). Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 38: 35-43
McEvoy, F.J.; Allen, G.R. 1972: 2-Phenyl-4H-cyclopentathiazole-4-carboxylic acids as potential antiinflammatory agents. Journal of Medicinal Chemistry 15(8): 850-851
Sabelli, H.C.; Vazquez, A.J.; Mosnaim, A.D.; Madrid-Pedemonte, L. 1974: 2-Phenylethylamine as a possible mediator for delta9-tetrahydrocannabinol-induced stimulation. Nature 248(5444): 144-145
Von Angerer, E.; Prekajac, J.; Strohmeier, J. 1984: 2-Phenylindoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat. Journal of Medicinal Chemistry 27(11): 1439-1447
Green, A.P.; Sweetman, A.J.; Hooper, M. 1971: 2-Phenylisatogen as an electron acceptor for mitochondrial NADH dehydrogenase. Journal of Pharmacy and Pharmacology 23: 249s
Diringer, H.; Heidelberger, C. 1969: 2-Phenylphenanthrene-3,2'-dicarboxylic acid is not bound to mouse skin proteins after application of 1,2,5,6-dibenzanthracene: a retraction. Cancer Research 29(11): 2127-2128
Auzzi, G.; Bruni, F.; Cecchi, L.; Costanzo, A.; Vettori, L.P.; Pirisino, R.; Corrias, M.; Ignesti, G.; Banchelli, G.; Raimondi, L. 1983: 2-Phenylpyrazolo[1,5-a]pyrimidin-7-ones. a new class of nonsteroidal antiinflammatory drugs devoid of ulcerogenic activity. Journal of Medicinal Chemistry 26(12): 1706-1709
Harris, R.N.; Anders, M.W. 1981: 2-Propanol treatment induces selectively the metabolism of carbon tetrachloride to phosgene. Implications for carbon tetrachloride hepatotoxicity. Drug Metabolism and Disposition: the Biological Fate of Chemicals 9(6): 551-556
McKenzie, W.L.; Foye, W.O. 1972: 2-Pyrazinecarboxanilides. Journal of Medicinal Chemistry 15(5): 570-571
Bandle, E.F.; Wendt, G.; Ranalder, U.B.; Trautmann, K.H. 1984: 2-Pyrrolidinone and succinimide endogenously present in several mammalian species. Life Sciences 35(22): 2205-2212
Lillehaug, J.R. 1980: 2-Step carcinogenesis. Significance of tumor promotors in the development of cancer. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 100(25): 1482-1485
Fugitt, R.B.; Roberts, R.M. 1973: 2-Substituted cinchoninic acids as intermediates in quinolinemethanol syntheses. Journal of Medicinal Chemistry 16(8): 875-879
Dziuron, P.; Schunack, W. 1974: 2-Substituted histamines. 3. Report on structure-activity relationships of histamine analogs. Archiv der Pharmazie 307(2): 89-95
Monforte, P.; Grasso, S.; Chimirri, A.; Fenech, G. 1981: 2-Substituted thiazole derivatives with possible antitumor activity. Il Farmaco; Edizione Scientifica 36(2): 109-115
Nagasawa, H.T.; Goon, D.J.; Muldoon, W.P.; Zera, R.T. 1984: 2-Substituted thiazolidine-4(R)-carboxylic acids as prodrugs of L-cysteine. Protection of mice against acetaminophen hepatotoxicity. Journal of Medicinal Chemistry 27(5): 591-596
Fontaine, J.G. 1967: 2-Sud, a therapeutic milieu. Laval Medical 38(9): 853-861
Darmaillacq, R.; Lesbats, G.; Conter, L. 1974: 2-Team perineoabdominal surgery in the treatment of genital prolapse in women. Chirurgie; Memoires de l'Academie de Chirurgie 100(8): 538-541
Tutwiler, G.F.; Ho, W.; Mohrbacher, R.J. 1981: 2-Tetradecylglycidic acid. Methods in Enzymology 72: 533-551
Claiborne, A.; Massey, V.; Fitzpatrick, P.F.; Schopfer, L.M. 1982: 2-Thioflavins as active site probes of flavoproteins. Journal of Biological Chemistry 257(1): 174-182
Würbach, G.; Klöcking, H.P. 1973: 2-Thiontetrahydro-1.3.5-thiadiazines with antifibrinolytic properties. Die Pharmazie 28(4): 254-257
Lloyd, W.; Fang, V.S.; Wells, H.; Tashjian, A.H. 1969: 2-Thiophenecarboxylic acid: a hypoglycemic, antilipolytic agent with hypocalcemic and hypophosphatemic effects in rats. Endocrinology 85(4): 763-768
Fang, V.S.; Minkin, C.; Goldhaber, P. 1971: 2-Thiophenecarboxylic acid: inhibitor of bone resorption in tissue culture. Science 172(3979): 163-165
Gough, G.; Maguire, M.H. 1965: 2-Trifluoromethyladenosine. Journal of Medicinal Chemistry 8(6): 866-867
Kapetanovic, E.; Bailey, J.M.; Colman, R.F. 1985: 2-[(4-Bromo-2,3-dioxobutyl)thio]adenosine 5'-monophosphate, a new nucleotide analogue that acts as an affinity label of pyruvate kinase. Biochemistry 24(26): 7586-7593
Haviv, F.; DeNet, R.W.; Michaels, R.J.; Ratajczyk, J.D.; Carter, G.W.; Young, P.R. 1983: 2-[(Phenylthio)methyl]pyridine derivatives: new antiinflammatory agents. Journal of Medicinal Chemistry 26(2): 218-222
Pang, C.S.; Ali, M.A.; Reddy, P.K.; Leatherland, J.F.; Brown, G.M.; Pang, S.F. 1994: 2-[125I]iodomelatonin binding in the brains of four salmonids. Biological Signals 3(5): 230-238
Nonno, R.; Lucini, V.; Stankov, B.; Fraschini, F. 1995: 2-[125I]iodomelatonin binding sites in the bovine hippocampus are not sensitive to guanine nucleotides. Neuroscience Letters 194(1-2): 113-116
Wan, Q.; Pang, S.F. 1995: 2-[125I]iodomelatonin binding sites in the quail liver: characterization and the effect of guanosine 5'-O-(3-thiotriphosphate). Biological Signals 4(1): 24-31
Song, Y.; Tam, P.C.; Poon, A.M.; Brown, G.M.; Pang, S.F. 1995: 2-[125I]iodomelatonin-binding sites in the human kidney and the effect of guanosine 5'-O-(3-thiotriphosphate). Journal of Clinical Endocrinology and Metabolism 80(5): 1560-1565
Engel, G.; Müller-Schweinitzer, E.; Palacios, J.M. 1984: 2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 325(4): 328-336
Meister, H.; Bachofen, R. 1984: 2-[8-14C]naphthyl 2-diazo-3,3,3-trifluoropropionate, a new carbene generating reagent for probing hydrophobic membrane domains. Biochimica et Biophysica Acta 771(1): 103-106
Viziano, M.; Ongini, E.; Conti, A.; Zocchi, C.; Seminati, M.; Pocar, D. 1995: 2-[N'-(3-arylallylidene)hydrazino]adenosines showing A2a adenosine agonist properties and vasodilation activity. Journal of Medicinal Chemistry 38(18): 3581-3585
Metzger, H.; Maier, R.; Sitter, C.; Stern, H.O. 1984: 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S) -2-azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498)--a new and highly effective angiotensin i converting enzyme inhibitor. Arzneimittel-Forschung 34(10b): 1402-1406
Unger, T.; Fleck, T.; Ganten, D.; Lang, R.E.; Rettig, F. 1984: 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats. Arzneimittel-Forschung 34(10b): 1426-1430
Melchiorre, C.; Brasili, L.; Giardinà, D.; Pigini, M.; Strappaghetti, G. 1984: 2-[[[2-(2,6-Dimethoxyphenoxy)ethyl]amino]-methyl] -1,4-benzoxathian: a new antagonist with high potency and selectivity toward alpha 1-adrenoreceptors. Journal of Medicinal Chemistry 27(12): 1535-1536
Stoffel, W.; Därr, W. 1974: 2-alkenal reductase isolation, properties and specificities. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 355(1): 54-60
Parmar, S.S.; Misra, R.S.; Chaudhari, A.; Gupta, T.K. 1972: 2-alkyl 1-(4'-Benzhydrazide)aminomethylbenzimidazoles as MAO inhibitors. Journal of Pharmaceutical Sciences 61(8): 1322-1324
Bień, I.; Domagalina, E. 1981: 2-alkylaminomethyl-benzoisoxazolin-3-ones. Acta Poloniae Pharmaceutica 38(1): 41-47
Gehlen, H.; Demin, P. 1970: 2-amino-1,3,4-oxadiazoles. 32. Ring opening of 2-imino-3-alkyl-5-aryl-1,3,4-oxadiazolines with carbazinic acid ethyl ester and consecutive reactions. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft 303(3): 263-267
Gehlen, H.; Uteg, K.H. 1969: 2-amino-1,3,4-oxdiazoles. 31. Preparation of 1-acyl-5-alkoxy(aroxy) carbonyl diaminoguanidines by opening of ring of 2-amino-1,3,4-oxdiazoles with carbazine acid esters. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft 302(11): 869-876
Gehlen, H.; Demin, P.; Uteg, K.H. 1970: 2-amino-1,3,4-oxdiazoles. 33. Preparation and reactions of in position-5 heterocyclic substituted 2-amino-1,3,4-oxdiazoles. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft 303(4): 310-317
Gehlen, H.; Demin, P. 1969: 2-amino-1,3,4-oxidazoles, 34. Conversion of 3,5-disubstituted 2-imino-1,3,4-oxdiazolines with mustard oils. Die Pharmazie 24(12): 728-730
Gehlen, H.; Uteg, K.H.; Vieweg, J. 1969: 2-amino-1,3,4-oxidazoles. 27. Hydroxyalkyl-substituted 2-amino-1,3,4-oxdiazoles. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft 302(2): 105-112
Jann, B.; Jann, K. 1968: 2-amino-2,6-dideoxy-L-mannose (L-rhamnosamine) isolated from the lipopolysaccharide of Escherichia coli 03:K2ab(L):H2. European Journal of Biochemistry 5(2): 173-177
Fujii, S.; Maruoka, M. 1982: 2-amino-2-deoxy-D-erythrose in Agaricus bisporus. Biochimica et Biophysica Acta 717(3): 486-490
König, H.; Kandler, O. 1980: 2-amino-2-deoxytaluronic acid and 2-amino-2-deoxyglucose from the pseudomurein of Methanobacterium termoautotrophicum possess the L- and D-configurations, respectively. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 361(6): 981-983
Klayman, D.L.; Shine, R.J.; Murray, A.E. 1970: 2-amino-2-oxazoline formation by cyclization of 1-(2-hydroxyethyl)-2-methyl-2-thiopseudoureas. Journal of Pharmaceutical Sciences 59(10): 1515-1518
Klayman, D.L.; Milne, G.W. 1969: 2-amino-2-thiazoline. VI. the formation of a thiazolo-S-triazine from 2-amino-2-thiazoline. Tetrahedron 25(1): 191-198
Claudi, F.; Felici, M.; Ferappi, M.; Grifantini, M. 1969: 2-amino-3-azirino-1,4-naphtoquinone and its derivatives with antitumor activity. Il Farmaco; Edizione Scientifica 24(8): 725-731
Suzuki, E.; Inoue, S.; Goto, T. 1968: 2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidine, its preparation and reaction. Chemical and Pharmaceutical Bulletin 16(5): 933-938
DeGraw, J.I.; Brown, V.H.; Cory, M.; Tsakotellis, P.; Kisliuk, R.L.; Gaumont, Y. 1971: 2-amino-4-hydroxy-6-arylaminoethylpteridines as potential antimalarial agents. Journal of Medicinal Chemistry 14(3): 206-210
Bird, O.D.; Vaitkus, J.W.; Clarke, J. 1970: 2-amino-4-hydroxyquinazolines as inhibitors of thymidylate synthetase. Molecular Pharmacology 6(5): 573-575
Mitchell, C.K.; Redburn, D.A. 1982: 2-amino-4-phosphonobutyric acid and N-methyl-D-aspartate differentiate between "3H]glutamate and [3H] aspartate binding sites in bovine retina. Neuroscience Letters 28(3): 241-246
Slaughter, M.M.; Miller, R.F. 1981: 2-amino-4-phosphonobutyric acid: a new pharmacological tool for retina research. Science 211(4478): 182-185
Miller, L.F.; Bambury, R.E. 1971: 2-amino-5-nitroimidazoles. Journal of Medicinal Chemistry 14(12): 1217-1218
Anonymous 1983: 2-amino-5-nitrothiazole. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 31: 71-77
Yale, H.L.; Losee, K. 1966: 2-amino-5-substituted 1,3,4-oxadiazoles and 5-imino-2-substituted delta-2-1,3,4-oxadiazolines. a group of novel muscle relaxants. Journal of Medicinal Chemistry 9(4): 478-483
Meyer, H.; Wehinger, E.; Bossert, F.; Stoepel, K.; Vater, W. 1981: 2-aminodihydropyridines / Structure and antihypertensive activity. Arzneimittel-Forschung 31(8): 1173-1177
Levene, C.; Harel, N. 1984: 2-aminoethylisothiouronium-treated red cells and the Cartwright (Yta) antigen. Transfusion 24(6): 541
Maenhaut-Michel, G.; Caillet-Fauquet, P. 1982: 2-aminopurine induced DNA repair in E. coli. Molecular and General Genetics: Mgg 188(1): 143-148
Büchel, K.H.; Schäfer, G. 1970: 2-anilinothiophenes, uncouplers of oxidative phosphorylation in mitochondria. Zeitschrift für Naturforschung. Teil B Chemie Biochemie Biophysik Biologie und verwandte Gebiete 25(12): 145-174
Anderson, V.B.; Allen, R.C. 1974: 2-aryl-3-dimethylphosphinylpropionic acids as potential nonsteroidal antiinflammatory agents. Journal of Medicinal Chemistry 17(10): 1117-1118
Schenone, S.; Bruno, O.; Ranise, A.; Bondavalli, F.; D'Amico, M.; Filippelli, W.; Falcone, G.; De Novellis, V. 1995: 2-aryl-3-phenylamino-4,5-dihydro-2H-benz[g]indazoles with antiarrhythmic and local anaesthetic activities. Farmaco 50(3): 179-182
Burger, A.; Zimmerman, S.E. 1966: 2-arylcyclobutylamines and -amino acids. Arzneimittel-Forschung 16(11): 1571-1572
Kreher, R.; Seubert, J. 1966: 2-arylisoindoles. Angewandte Chemie 5(11): 967-968
Trybulski, E.J.; Benjamin, L.E.; Earley, J.V.; Fryer, R.I.; Gilman, N.W.; Reeder, E.; Walser, A.; Davidson, A.B.; Horst, W.D.; Sepinwall, J. 1983: 2-benzazepines. 5. Synthesis of pyrimido[5,4-d][2]benzazepines and their evaluation as anxiolytic agents. Journal of Medicinal Chemistry 26(11): 1589-1596
Trybulski, E.J.; Fryer, R.I.; Reeder, E.; Walser, A.; Blount, J. 1983: 2-benzazepines. 6. Synthesis and pharmacological properties of the metabolites of 9-chloro-7-(2-chlorophenyl)-5H-pyrimido[5,4-d] [2]benzazepine. Journal of Medicinal Chemistry 26(11): 1596-1601
Smith, S.C.; Dunn, F.W. 1969: 2-benzyl-5-(N,N-dimethylamino)-gamma-valerolactone, an inhibitor of plasma cholinesterase. Journal of Medicinal Chemistry 12(4): 701
Smith, S.C.; Dunn, F.W. 1969: 2-benzyl-5-aminolevulinic acid, an analog of glycyl-dl-phenylalanine. Journal of Medicinal Chemistry 12(4): 699-700
Robins, R.K.; Srivastava, P.C.; Narayanan, V.L.; Plowman, J.; Paull, K.D. 1982: 2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases. Journal of Medicinal Chemistry 25(2): 107-108
Welsch, C.W.; Goodrich-Smith, M.; Brown, C.K.; Mackie, D.; Johnson, D. 1982: 2-bromo-alpha-ergocryptine (CB-154) and tamoxifen (ICi 46,474) induced suppression of the genesis of mammary carcinomas in female rats treated with 7,12-dimethylbenzanthracene (DMBA): a comparison. Oncology 39(2): 88-92
Nantka-Namirski, P.; Ozdowska, Z. 1974: 2-carbethoxyindole derivatives. III. Some amide derivatives and products of alkylation of 5-benzyloxy- and 5-methoxy-2-carbethoxyindole. Acta Poloniae Pharmaceutica 31(5): 569-576
Lieberman, R.; Mushinski, J.F.; Potter, M. 1968: 2-chain immunoglobulin a molecules: abnormal or normal intermediates in synthesis. Science 159(3821): 1355-1357
Lisitskiĭ, A.V.; Legostaev, G.N. 1981: 2-chamber apparatus for studying group behavior in mice. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 31(6): 1316-1317
Harada, Y.; Inoue, H.; Saigusa, M. 1974: 2-chambered right ventricle. Nihon Kyobu Geka Gakkai 22(12): 1139-1146
Kuras, A.V.; Khusainovene, N.P. 1983: 2-channel carbon-fiber microelectrode. Fiziologicheskii Zhurnal SSSR Imeni I. M. Sechenova 69(9): 1250-1252
Nikolaev, I.A.; Dogadov, A.A.; Ovoshchnikov, V.N. 1980: 2-channel digital meter of interspike intervals with conversion to a binary-decimal code. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 30(5): 1095-1098
Kanishchev, P.A.; Bereza, N.M.; Zhivago, I.M.; Chelnokova, E.L. 1984: 2-channel gastric probe. Vrachebnoe Delo 10: 30-32
Rozanov, I.M.; Barskiĭ, I.I.; Borovikov, I.S. 1970: 2-channel polarization microfluorimeter. Tsitologiia 12(11): 1477-1480
Gross, A.; Thiele, K.; Schuler, W.A.; von Schlichtegroll, A. 1968: 2-chlor-4-azaphenthiazine. Synthesis and pharmacological properties of cloxypendyl. Arzneimittel-Forschung 18(4): 435-442
Nalda Felipe, M.A.; López Timoneda, F. 1974: 2-chloro-1,1,2-trifluoroethyl-difluoromethyl-ether (ethrane), in anesthesiology. Revista Espanola de Anestesiologia y Reanimacion 21(2): 144-177
Magarian, R.A.; Melton, S.; Natarelli, G. 1972: 2-chloro-1-phenylindene from 1,1-dichloro-trans-2,3-diphenylcyclopropane. Journal of Pharmaceutical Sciences 61(8): 1216-1219
Angst, J.; Cornu, F.; Heimann, H.; Pöldinger, W.; Steiner, H. 1970: 2-chloro-11(4'-methylpiperazino)-dibenzo-(b,f)(1,4)-oxazepine (Sum 3170), a new neuroleptic. Results of clinical testing. Arzneimittel-Forschung 20(7): 967-970
Gough, G.; Maguire, M.H.; Michal, F. 1969: 2-chloroadenosine 5'-phosphate and 2-chloroadenosine 5'-diphosphate, pharmacologically active nucleotide analogs. Journal of Medicinal Chemistry 12(3): 494-498
Lerner, U.; Fredholm, B.B. 1982: 2-chloroadenosine increases calcium mobilization from mouse calvaria in vitro. Acta Endocrinologica 100(2): 313-320
Iogannsen, M.G. 1982: 2-component non-carcinogenic chromogen for the detection of occult blood. Laboratornoe Delo 10: 21-24
Vakhova, G. 1973: 2-cycle system of work organization and complex biochemical examination of patients at a laboratory of a district hospital. Laboratornoe Delo 7: 427-429
McCann, J.S.; Horner, T.; Shepherd, I.; Quin, N. 1974: 2-day treatment of trichomoniasis with nimorazole. British Journal of Venereal Diseases 50(5): 375-376
Gardiner, P.J.; Copas, J.L.; Schneider, C.; Collier, H.O. 1980: 2-decarboxy-2-hydroxymethyl prostaglandin E1 (TR4161), a prostaglandin bronchodilator of low tracheobronchial irritancy. Prostaglandins 19(3): 349-370
Félix, H.; Freyria, J.; Maillard, A. 1966: 2-dehydroemetine administered by the oral route in the treatment of amebiasis. Therapeutic trials. Journal de Medecine de Lyon 47(104): 1211-1216
Levy, S.; Livni, E.; Elmaleh, D.R.; Varnum, D.A.; Brownell, G.L. 1983: 2-deoxy-2-[18F]fluoro-3-o-methyl-D-glucose synthesis and animal biodistribution studies. International Journal of Applied Radiation and Isotopes 34(11): 1560-1562
Tadanier, J.; Hallas, R. 1982: 2-deoxy-3-demethoxyfortimicin a. Journal of Antibiotics 35(6): 688-691
Nakagawa, H.; Nishimura, M.; Urakawa, N. 1983: 2-deoxy-D-glucose stimulates acid secretion from chicken proventriculus. Nihon Juigaku Zasshi. Japanese Journal of Veterinary Science 45(6): 721-726
Ferraris, A.M.; Giuntini, P.; Galiano, S.; Gaetani, G.F. 1981: 2-deoxy-glucose-6-phosphate utilization in the study of glucose-6-phosphate dehydrogenase mosaicism. American Journal of Human Genetics 33(2): 307-313
Singer, P.; Mehler, S. 1980: 2-deoxy[14C]glucose uptake in the rat hypoglossal nucleus after nerve transection. Experimental Neurology 69(3): 617-626
Toop, J.; Burke, R.E.; Dum, R.P.; O'Donovan, M.J.; Smith, C.B. 1982: 2-deoxyglucose autoradiography of single motor units: labeling of individual acutely active muscle fibers. Journal of Neuroscience Methods 5(3): 283-289
Hoffee, P.A. 1968: 2-deoxyribose-5-phosphate aldolase of Salmonella typhimurium: purification and properties. Archives of Biochemistry and Biophysics 126(3): 795-802
Seif, F.J.; Faber, K. 1968: 2-desoxy-d-glucose for determination of functional reserve of the adrenal medulla in Addison's disease. Die Medizinische Welt 42: 2264-2267
Chatterjee, S. 1967: 2-dicyanomethylene-1,3-indanedione: a new electron acceptor. Science 157(3786): 314-316
Sugár, L. 1972: 2-digit system for tooth numbering. Fogorvosi Szemle 65(1): 27-28
Volkova, V.I.; Gaziez, G.A.; Popova, L.A. 1970: 2-dimensional chromatography of a corticosteroid mixture on thin layer of KSK silica-gel. Voprosy Meditsinskoi Khimii 16(1): 101-103
Neuhoff, V.; von der Haar, F.; Schlimme, E.; Weise, M. 1969: 2-dimensional chromatography of dansyl amino acids in pico-mole quantities, applied to the direct characterization of transfer ribonucleic acids. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 350(2): 121-128
Obojska, K.; Kolodyńska, Z.; Wieniawski, W. 1971: 2-dimensional chromatography of rat bile. Acta Poloniae Pharmaceutica 28(4): 439-443
Piot, J.D.; David, P.; Touchot, A.; Zeitouni, R.; Piot, C.; Binet, J.P. 1983: 2-dimensional contrast echocardiographic diagnosis of associated atrioventricular canal and cor triatriatum. Archives des Maladies du Coeur et des Vaisseaux 76(5): 632-635
Chin, A.J.; Bierman, F.Z.; Williams, R.G.; Sanders, S.P.; Lang, P. 1983: 2-dimensional echocardiographic appearance of complete left-sided juxtaposition of the atrial appendages. American Journal of Cardiology 52(3): 346-348
Wester, H.A. 1983: 2-dimensional echocardiographic diagnosis in morphological heart changes. Die Medizinische Welt 34(42): 1176-1178
Rey, C.; Piot, J.D.; Bourlon, F.; Cloez, J.L.; Fermont, L. 1984: 2-dimensional echocardiographic diagnosis of an intracardiac thrombus in children. Archives des Maladies du Coeur et des Vaisseaux 77(5): 503-509
Saunamäki, K.I.; Grande, P. 1984: 2-dimensional echocardiographic evaluation of left ventricular dyssynergy after acute myocardial infarction. Ugeskrift for Laeger 146(48): 3746-3750
Fonseca Wanderly Braga, A.M.; Mesa, A.; Peña Flores, H.; García Cornejo, M.; Arenas, J.L.; Esquivel-Avila, J.G. 1984: 2-dimensional echocardiographic measurement of the valvular area in mitral stenosis. Surgical correlations. Archivos del Instituto de Cardiologia de Mexico 54(3): 253-258
Widimský, P.; Gregor, P.; Cervenka, V.; Vísek, V.; Dvorák, J.; Sládková, T. 1982: 2-dimensional echocardiography in acute myocardial infarct. Vnitrni Lekarstvi 28(6): 540-546
Gregor, P.; Widimský, P.; Cervenka, V.; Sládková, T.; Dvorák, J.; Vísek, V. 1982: 2-dimensional echocardiography in cardiomyopathies. Vnitrni Lekarstvi 28(6): 534-539
Rodríguez-López, A.M.; Huerta, D.; Velasco, P.; Guadalajara, J.; Esquivel, J.; Lara, R.; De los Ríos, M.; Gil, M. 1984: 2-dimensional echocardiography in fixed fibrous subaortic stenosis. Correlation with hemodynamics and M-mode echocardiography. Archivos del Instituto de Cardiologia de Mexico 54(1): 11-19
García-Fernández, M.A.; Bañuelos, F.; Moreno, M.; Suzacq, C.; Asinger, R. 1982: 2-dimensional echocardiography in left auricular thrombosis. Revista Espanola de Cardiologia 35(2): 147-150
Pennestrì, F.; Loperfido, F.; Salvatori, M.P.; Mongiardo, R.; Mazzari, M.; Montenero, A.S.; Coppola, E. 1982: 2-dimensional echocardiography in performing myocardial biopsy. Cardiologia 27(12): 1141-1144
Zubkova, G.A.; Zodelava, E.Z.; Garibian, V.A. 1984: 2-dimensional echocardiography in the diagnosis of complete transposition of the great vessels in children under 1-year old. Pediatriia 1984(5): 24-27
Golikov, A.P.; Charchoglian, R.A.; Kipiani, M.A.; Avdeeva, I.I. 1981: 2-dimensional echocardiography in the diagnosis of heart aneurysms. Kardiologiia 21(9): 61-64
Enia, F.; Bella, R.; Celona, G.; Filippone, V.; Grasso, S. 1981: 2-dimensional echocardiography in the evaluation of patients with mitral insufficiency. Bollettino Della Societa Italiana di Cardiologia 26(7): 631-644
Pennestrì, F.; Loperfido, F.; Salvatori, M.P.; Mongiardo, R.; Mazzari, M.; Montenero, A.S.; Coppola, E. 1982: 2-dimensional echocardiography in the execution of myocardial biopsy. Cardiologia 27(12): 1141-1145
Piot, J.D.; Rey, C.; Guérinon, J.; Lucet, P.; Pernot, C.; Binet, J.P. 1984: 2-dimensional echocardiography of congenital obstruction of left ventricle inflow. Apropos of 25 cases. Archives des Maladies du Coeur et des Vaisseaux 77(5): 510-516
Nesje, O.A.; Wallentin, I. 1984: 2-dimensional echocardiography. a non-invasive examination method. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 104(2): 101-105
Tomov, I. 1980: 2-dimensional echocardiography: principles, methods and the normal images. Vutreshni Bolesti 19(4): 86-95
Gebauer, A.; Valena-Eberhard, D.; Zrenner, M.; Becker-Gaab, C.; Kessler, M.; Hahn, D. 1983: 2-dimensional echoencephalography or cranial CT in premature or newborn infants with suspected intracranial hemorrhages. Computertomographie 3(2): 51-56
Enriquez-Sarano, M.; Dunica, S.; Sergent, J.; Charbel, P.; Acar, J. 1984: 2-dimensional echography in the preoperative evaluation of mitral stenosis. Archives des Maladies du Coeur et des Vaisseaux 77(6): 642-651
Wolf, M.; Wordsworth, W. 1968: Existential psychology and a romantic poem. Psychiatric Quarterly 42(2): 297-302
Ashmarin, I.P.; Kharchenko, E.P.; Loĭtsianskaia, M.S. 1971: 2-dimensional grouping of bacteria according to DNA content and its nucleotide composition. Mikrobiologiia 40(1): 133-138
Martin, P.; Bedoucha, P.; Fantin, J.; Denis, G.; Borg, M.; Michel, A.M. 1982: 2-dimensional immunoelectrophoresis and cerebrospinal fluid protein profile in optic neuropathies and uveitis. Revue d'Oto-Neuro-Ophtalmologie 54(4): 285-304
Walbaum, S.; Vaucelle, T.; Biguet, J. 1973: 2-dimensional immunoelectrophoretic analysis of Micropolyspora faeni extract. Localization of chymotrypsic activity. Pathologie-Biologie 21(4): 355-358
Saint-Paul, M.; Rebeyrotte, P.; Dérobert, L.; Peillet, J.; Labbé, J.P. 1973: 2-dimensional immunoelectrophoretic studies on the degradation of serum proteins by decay. Beitrage Zur Gerichtlichen Medizin 30: 376-381
Kato, H. 1983: 2-dimensional micrometry to measure displacement of the periodontal tissues in the molar area. Kokubyo Gakkai Zasshi. Journal of the Stomatological Society Japan 50(1): 153
Jeannerod, M.; Gerin, P.; Rougier, J. 1966: 2-dimensional recording of ocular movements and pauses. Apropos of a new method. Revue d'Oto-Neuro-Ophtalmologie 38(1): 51-53
Pinsler, G.; Ritter, E.P.; Rahn, H.; Keiner, P. 1982: 2-dimensional representation of dose distributions on a color video monitor. Radiobiologia Radiotherapia 23(6): 641-645
Spranger, H. 1972: 2-dimensional representation of the osseous limbus alveolaris using ultrasonic impulse echo diagram. Deutsche Zahnarztliche Zeitschrift 27(3): 197-202
Margolis, J.; Kenrick, K.G. 1969: 2-dimensional resolution of plasma proteins by combination of polyacrylamide disc and gradient gel electrophoresis. Nature 221(5185): 1056-1057
Székács, I.; Klembala, M. 1967: 2-dimensional thin layer chromatography of lipids. Orvosi Hetilap 108(53): 2512-2514
Merkle, K.; Khlebnikova, N.L. 1983: 2-dimensional ultrasonic scanning for irradiation planning. Meditsinskaia Radiologiia 28(6): 35-40
Arabidze, G.G.; Megrelishvili, R.I. 1984: 2-dimensional ultrasonic scanning of the abdominal aorta in arterial hypertension patients. Kardiologiia 24(9): 95-98
Albarello, B. 1982: 2-dimensional visual objects as a possible transition from n-dimensional to 3-dimensional reality. Clinical study. Minerva Psichiatrica 23(3-4): 121-128
Magherini, A.; Azzolina, G.; Maffei, G.; Marchese, A.; Russo, P.A. 1981: 2-dimensional-echodoppler "integrated echography": Ebstein's anomaly. Uhl's anomaly. Bollettino Della Societa Italiana di Cardiologia 26(11): 1811-1815
Blauenstein, U.W.; Müller, H.R. 1969: 2-dimensonal sonography in the upper abdominal area. Medizinische Klinik 64(22): 1055-1057
Hoffmann, I.; Kuch, H.; Schmitt, K.; Seidl, G. 1970: 2-ethylamino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine, a new psychotropic compound. Arzneimittel-Forschung 20(7): 975
Anonymous 1994: 2-ethylhexyl acrylate. IARC monographs on the evaluation of carcinogenic risks to humans 60: 475-486
Ushakov, I.B.; Karpov, V.N. 1981: 2-factor design of nonuniform gamma irradiation of rats at high dosages. Radiobiologiia 21(6): 884-888
Avramis, V.I.; Plunkett, W. 1983: 2-fluoro-ATP: a toxic metabolite of 9-beta-D-arabinosyl-2-fluoroadenine. Biochemical and Biophysical Research Communications 113(1): 35-43
Sarantakis, D.; Sutherland, J.K.; Tortorella, C.; Tortorella, V. 1968: 2-fluoropyridine N-oxide and its reactions with amino-acid derivatives. Journal of the Chemical Society. Perkin Transactions 1 1: 72-73
Gomarasca, M. 1971: 2-formyl-11-alpha-hydroxy-delta 1-methyltestosterone: a new anabolic water-soluble steroid. Minerva Medica 62(17): 842-845
Shealy, Y.F.; Krauth, C.A.; Struck, R.F.; Montgomery, J.A. 1983: 2-haloethylating agents for cancer chemotherapy. 2-haloethyl sulfonates. Journal of Medicinal Chemistry 26(8): 1168-1173
Ebina, S.; Nagai, Y.; Uedaira, H. 1982: 2-halogeno-ethanols as denaturant of protein. Activity coefficient of N-acetyl ethyl esters of aromatic amino acids in 2-fluoroethanol, 2,2,2-trifluoroethanol, 2-chloroethanol, 2-bromoethanol, 1-propanol, and ethanol. Fukushima Journal of Medical Science 28(3-4): 83-92
Cowlen, M.S.; Hewitt, W.R.; Schroeder, F. 1984: 2-hexanone potentiation of [14C]chloroform hepatotoxicity: covalent interaction of a reactive intermediate with rat liver phospholipid. Toxicology and Applied Pharmacology 73(3): 478-491
Anonymous 1969: 2-hexanone. (Methylbutyl ketone, MBK). American Industrial Hygiene Association Journal 30(6): 646-647
Busse, K.; Schwarzhaupt, W. 1973: 2-hour creatinine clearance, a simple kidney function test in general practice. Helvetica Chirurgica Acta 40(4): 485-487
Lubimowski, B.; Berezowski, L. 1969: 2-hydrazine-methyl-quinazolone and 2-thiolmethylquinazolone-4 and their transformation. Acta Poloniae Pharmaceutica 26(4): 293-300
Yano, I.; Furukawa, Y.; Kusunose, M. 1970: 2-hydroxy fatty acid-containing phospholipid of Arthrobacter simplex. Biochimica et Biophysica Acta 210(1): 105-115
Greter, J.; Lindstedt, S.; Seeman, H.; Steen, G. 1980: 2-hydroxy-2-methylsuccinic acid--a urinary metabolite in propionyl-CoA carboxylase deficiency. Clinica Chimica Acta; International Journal of Clinical Chemistry 106(1): 103-106
Tsou, K.C.; Matsukawa, S. 1968: 2-hydroxy-3-naphthoic acid anilide phosphate as a fluorescent histochemical substrate for phosphatase. Journal of Medicinal Chemistry 11(5): 1097-1099
Huszti, Z.; Kasztreiner, E.; Kürti, M.; Fekete, M.; Borsy, J. 1973: 2-hydroxy-5-carbomethoxybenzyloxyamine: a new potent inhibitor of histidine decarboxylase. Biochemical Pharmacology 22(18): 2253-2265
Merriam, G.R.; MacLusky, N.J.; Johnson, L.A.; Naftolin, F. 1980: 2-hydroxyestradiol-17 alpha and 4-hydroxyestradiol-17 alpha, catechol estrogen analogs with reduced estrogen receptor affinity. Steroids 36(1): 13-20
Nikawa, J.; Yamashita, S. 1983: 2-hydroxyethylhydrazine as a potent inhibitor of phospholipid methylation in yeast. Biochimica et Biophysica Acta 751(2): 201-209
Raxworthy, M.J.; Gulliver, P.A. 1982: 2-hydroxyethynyloestradiol as a substrate for catechol-O-methyltransferase--implications in the metabolism of ethynyloestradiol. Journal of Steroid Biochemistry 17(1): 17-21
Kindzel'skiĭ, L.P.; Sribnaia, A.F. 1972: 2-indicator radioisotope method of studying the function of the spleen. Meditsinskaia Radiologiia 17(1): 53-56
Bagot, J.; Siffert, O.; Millet, B. 1969: 2-indolyl malonic acids and derivatives. Bulletin de la Societe Chimique de France (3): 917-920
Tabin, V.I. 1973: 2-joint muscles of the hip in albino rats with congenital malformations of the pelvic extremities. Arkhiv Anatomii Gistologii i Embriologii 65(11): 13-19
Claus, D. 1965: 2-keto-3-deoxygalactonic acid as a constituent of an extra-cellular polysaccharide of Azotobacter vinelandii. Biochemical and Biophysical Research Communications 20(6): 745-751
Fradkin, J.E.; Fraenkel, D.G. 1971: 2-keto-3-deoxygluconate 6-phosphate aldolase mutants of Escherichia coli. Journal of Bacteriology 108(3): 1277-1283
Bender, R.; Andreesen, J.R.; Gottschalk, G. 1971: 2-keto-3-deoxygluconate, an intermediate in the fermentation of gluconate by clostridia. Journal of Bacteriology 107(2): 570-573
Dahms, A.S.; Anderson, R.L. 1969: 2-keto-3-deoxyl-L-arabonate aldolase and its role in a new pathway of L-arabinose degradation. Biochemical and Biophysical Research Communications 36(5): 809-814
Lane, R.S.; Shapley, A.; Dekker, E.E. 1971: 2-keto-4-hydroxybutyrate aldolase. Identification as 2-keto-4-hydroxyglutarate aldolase, catalytic properties, and role in the mammalian metabolism of L-homoserine. Biochemistry 10(8): 1353-1364
Lane, R.S.; Dekker, E.E. 1969: 2-keto-4-hydroxybutyrate. Synthesis, chemical properties, and as a substrate for lactate dehydrogenase of rabbit muscle. Biochemistry 8(7): 2958-2966
Allard, P.; Dinh, T.H.; Gouyette, C.; Igolen, J.; Chermann, J.C.; Barré-Sinoussi, F. 1981: 2-l-Rhamnopyranosyl[1,2,4]triazolo[1,5-a]pyridine. 4' and 3' Oxidation products. Synthesis and structure-activity relationships. Journal of Medicinal Chemistry 24(11): 1291-1297
Mikhailov, M. 1970: 2-layer suture in gastrointestinal and intestino-intestinal anastomosis. Khirurgiia 23(3): 217-219
Pizio, Z.; Gluch, H. 1971: 2-level osteotomy in the treatment of osteoarthritis of the knee. Chirurgia Narzadow Ruchu i Ortopedia Polska 36(6): 769-775
Cutroneo, K.R.; Bresnick, E. 1971: 2-mercapto-1-( -4-pyridethyl) benzimidazole, an inhibitor of RNA synthesis: a reevaluation. Biochemical and Biophysical Research Communications 45(1): 265-269
Schweisfurth, H. 1995: 2-mercaptobenzothiazole in baby pacifiers. Deutsche Medizinische Wochenschrift 120(31-32): 1102-1103
Moys, A.; Blöckinger, G.; Schwartz, E.; Selecký, F.V.; Vrbovský, L. 1966: 2-mercaptobenzothiazole in the clinical experiment. Ceskoslovenska Dermatologie 41(6): 408-413
Johnson, G.A.; Boukma, S.J.; Platz, P.A. 1970: 2-mercaptobenzothiazole, an inhibitor of dopamine beta-hydroxylase. Journal of Pharmacy and Pharmacology 22(9): 710-712
Buchanan, T.M.; Faber, L.C. 1980: 2-mercaptoethanol Brucella agglutination test: usefulness for predicting recovery from brucellosis. Journal of Clinical Microbiology 11(6): 691-693
Triolo, L.; Magris, D.; Mian, G. 1980: 2-mercaptopropionylglycine in the treatment of the hyperviscosity syndrome. Haematologica 65(1): 135
Păunescu, L.; Oiţă, N.; Fişel, S.; Năstasă, V. 1982: 2-methionine phenothiazine derivatives with antibacterial action. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 86(3): 475-479
Gerson, T.; Schlenk, H. 1968: 2-methyl substituted and 2-enoic fatty acids by Favorsky rearrangement of haloketones. Chemistry and Physics of Lipids 2(2): 213-219
Bicher, H.I. 1970: 2-methyl-2-tert. butyl-ketolactone, an anti-adhesive drug preventing platelet and red cell aggregation. Pharmacology 4(3): 152-162
Midha, K.K.; Coutts, R.T.; Hubbard, J.W.; Prasad, K. 1970: 2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride--a new hypotensive agent. European Journal of Pharmacology 11(1): 48-55
Waterhouse, D.F.; Wallbank, B.E. 1967: 2-methylene butanal and related compounds in the defensive scent of Platyzosteria cockroaches (Blattidae: Polyzosteriinae). Journal of Insect Physiology 13(11): 1657-1659
Hottiger, T.; Kuhla, J.; Pohlig, G.; Fürst, P.; Spielmann, A.; Garn, M.; Haemmerli, S.; Heim, J. 1995: 2-micron vectors containing the Saccharomyces cerevisiae metallothionein gene as a selectable marker: excellent stability in complex media, and high-level expression of a recombinant protein from a CUP1-promoter-controlled expression cassette in cis. Yeast 11(1): 1-14
Bukotkin, V.N. 1972: 2-moment rupture of the liver. Vestnik Khirurgii Imeni I. I. Grekova 108(2): 111
Olsen, R.K.; Daves, G.D.; Moore, H.W.; Folkers, K.; Parson, W.W.; Rudney, H. 1966: 2-multiprenylphenols and 2-decaprenyl-6-methoxyphenol, biosynthetic precursors of ubiquinones. Journal of the American Chemical Society 88(24): 5919-5923
Riccio, P.; Günther, H.; Quagliariello, E. 1981: 2-n-nonyl-4-hydroxy[3-3H]quinoline N-oxide: interaction with the mitochondrial membrane. European Journal of Biochemistry 114(1): 153-157
Eiden, F.; Plückhan, J. 1969: 2-nitro-3-hydroxy-4-pyrones. 22. Studies on 4-pyrones. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft 302(8): 622-627
Rehavi, M.; Ittah, Y.; Rice, K.C.; Skolnick, P.; Goodwin, F.K.; Paul, S.M. 1981: 2-nitroimipramine: a selective irreversible inhibitor of [3H] serotonin uptake and [3H] imipramine binding in platelets. Biochemical and Biophysical Research Communications 99(3): 954-959
Gleason, J.G.; Ku, T.W.; McCarthy, M.E.; Weichman, B.M.; Holden, D.; Osborn, R.R.; Zabko-Potapovich, B.; Berkowitz, B.; Wasserman, M.A. 1983: 2-nor-leukotriene analogs: antagonists of the airway and vascular smooth muscle effects of leukotriene C4, D4 and E4. Biochemical and Biophysical Research Communications 117(3): 732-739
Maliovanova, S.D.; Reznikov, K.I. 1967: 2-nucleic neurons in the cerebral cortex of the rat. Doklady Akademii Nauk SSSR 175(2): 460-462
Dyen, M.E.; Swern, D. 1967: 2-oxazolidones. Chemical Reviews 67(2): 197-246
Lenzen, S.; Panten, U. 1980: 2-oxocarboxylic acids and function of pancreatic islets in obese-hyperglycaemic mice. Insulin secretion in relation to 45Ca uptake and metabolism. Biochemical Journal 186(1): 135-144
Strumilo, S.A.; Taranda, N.I.; Senkevich, S.B.; Vinogradov, V.V. 1981: 2-oxoglutarate dehydrogenase complex from bovine-adrenal-cortex mitochondria. Purification and partial characterization. Acta Biologica et Medica Germanica 40(3): 257-264
Woolfolk, C.A.; Woolfolk, B.S.; Whiteley, H.R. 1970: 2-oxypurine dehydrogenase from Micrococcus aerogenes. I. Isolation, specificity, and some chemical and physical properties. Journal of Biological Chemistry 245(12): 3167-3178
Holler, E.; Bennett, E.L.; Calvin, M. 1971: 2-p-Toluidinylnaphthalene-6-sulfonate, a fluorescent reporter group for L-isoleucyl-tRNA synthetase. Biochemical and Biophysical Research Communications 45(2): 409-415
Gutsche, H. 1970: 2-part evaluation of glucose tolerance. Medizinische Klinik 65(39): 1698-1700
Krocin, A. 1970: 2-part silicone-plaster molds for the reproduction of tooth models. Protetyka Stomatologiczna 20(4): 265-268
Rehrmann, A. 1972: 2-phage surgery of mandibular cystic adamantinomas. Fortschritte der Kiefer- und Gesichts-Chirurgie 15: 195-202
Mosonyi, L. 1968: 2-phase pathogenesis of some autonomic-allergic clinical symptoms. Wiener Zeitschrift für Innere Medizin und ihre Grenzgebiete 49(8): 300-307
Májský, A. 1972: 2-phase pronase test. a new rapid technic for determination of incomplete antibodies. Casopis Lekaru Ceskych 111(28): 645-646
Priiatkina, T.N.; Sharygin, A.A.; Ashmarin, I.P. 1973: 2-phase release of chromatin from cell nuclei during the action of ultrasonics. Tsitologiia 15(9): 1117-1121
Arlart, I.P. 1984: 2-phase summation imaging of the subclavian steal syndrome using transvenous DSA. Rontgen-Blatter; Zeitschrift für Rontgen-Technik und Medizinisch-Wissenschaftliche Photographie 37(7): 242-244
Staskun, B. 1966: 2-phenyl-3-(1-methyl-2-indolyl)-4(1H)-quinolone. Journal of Organic Chemistry 31(8): 2674-2676
Buchmann, G.; Völtzke, W. 1969: 2-phenyl-3-indolyl methylation of methylene active compounds. Die Pharmazie 24(8): 446-450
Segovia, J.; Flitas, F. 1966: 2-phenylalanine-8-lysine vasopressin as a vasoconstrictor agent in obstetrical wounds. (Episiotomy and perineal tears). Revista de Obstetricia y Ginecologia de Venezuela 26(4): 751-757
Koehler, K.A.; Lienhard, G.E. 1971: 2-phenylethaneboronic acid, a possible transition-state analog for chymotrypsin. Biochemistry 10(13): 2477-2483
Pestka, J.J.; Delwiche, E.A. 1981: 2-phosphoglycerate phosphatase and serine biosynthesis in Veillonella alcalescens. Canadian Journal of Microbiology 27(8): 808-814
Vsevolodov, N.N.; Kostikov, L.P.; Kaiushin, L.P.; Gorbatenkov, V.I. 1973: 2-photon absorption of laser radiation by chlorophyll a and organic dyes. Biofizika 18(4): 755-757
Schäufele, U.; Tvedten, F. 1971: 2-physician station in Alvsbyn, Norrbotten County. Lakartidningen 68(5): 428-431
Villain, R. 1973: 2-plane projection cephalometry based on descriptive geometry (Monge). L' Orthodontie Francaise 44(1): 483-495
Lesný, I. 1970: 2-point discrimination disorders in cerebral palsy. Ceskoslovenska Pediatrie 25(3): 138-142
Ginter, E.; Cerven, J.; Nemec, R.; Mikus, L.; Jankela, J. 1972: 2-pool analysis of cholesterol metabolism in normal guinea pigs. Bratislavske Lekarske Listy 58(4): 400-407
Hörer, O.L.; Enache, C. 1983: 2-propanol dependent RNA absorbance. Virologie 34(4): 257-272
Ishikawa, S.; Ueda, I.; Yoneyama, T.; Watanabe, K. 1967: 2-pyridine aldoxime methiodide in the treatment of post-operative acute pulmonary edema: possible role of cholinesterase. Japanese Heart Journal 8(6): 744
Harper, J.F. 1995: 2-pyridones. Lancet 346(8968): 186-187
Kersten, P.J.; Dagley, S.; Whittaker, J.W.; Arciero, D.M.; Lipscomb, J.D. 1982: 2-pyrone-4,6-dicarboxylic acid, a catabolite of gallic acids in Pseudomonas species. Journal of Bacteriology 152(3): 1154-1162
Porstmann, B.; Porstmann, T.; Schmechta, H.; Nugel, E.; Seifert, R.; Lukowsky, A.; Evers, U.; Mielke, F.; Egger, E. 1982: 2-sided binding immunoenzyme assay using various marker enzymes and marking procedures. Zeitschrift für Medizinische Laboratoriumsdiagnostik 23(5): 285-291
Sidi, D.; Kachaner, J.; Batisse, A.; Hazan, E.; Lecompte, Y.; Fermont, L.; Villain, E.; Piechaud, J.F. 1984: 2-stage anatomic correction of simple transposition of the great vessels. Annales de Pediatrie 31(7): 587-590
Bochkareva, A.A.; Ivanishko, I.A. 1982: 2-stage argon laser coagulation of macular tears. Vestnik Oftalmologii 5: 59-61
Podmaĭstrovich, V.I. 1966: 2-stage closed echinococcotomy in congenital diverticulum of the small intestine. Klinicheskaia Khirurgiia 8: 72-73
Terent'ev, V.A. 1969: 2-stage closure of high intestinal fistula associated with large intestinal and urinary fistula. Vestnik Khirurgii Imeni I. I. Grekova 103(11): 127-129
Horio, S.; Fujiwara, Y.; Okabayashi, H.; Kanzaki, Y.; Kameyama, J.; Baba, K. 1983: 2-stage correction of interrupted aortic arch. Nihon Geka Hokan. Archiv für Japanische Chirurgie 52(3): 407-411
Kolesnikov, I.P. 1981: 2-stage correction of varus deformity of the femur neck. Ortopediia Travmatologiia i Protezirovanie 1981(10): 55-56
Pendl, G. 1970: 2-stage development of an epidural hematoma from an angiographically proven meningeal injury. Wiener Medizinische Wochenschrift 120(47): 877-878
Burian, K. 1972: 2-stage endocranio-transsphenoidal approach in pituitary tumors. Monatsschrift für Ohrenheilkunde und Laryngo-Rhinologie 106(1): 23-26
Laage, G.; Zipfel, L. 1966: 2-stage endoscopic diverticular surgery. Case report. Das Deutsche Gesundheitswesen 21(32): 1531-1534
Drobny, T.K.; Munzinger, U.K.; Chomiak, J. 1995: 2-stage exchange in the treatment of infected knee prosthesis. Der Orthopade 24(4): 360-366
Belusa, M.; Schmickaly, J.; Wiedersberg, H. 1984: 2-stage flexor tendon transplantation--surgical technic--histology--results. Beitrage Zur Orthopadie und Traumatologie 31(2): 89-94
Nally, J.N. 1971: 2-stage functional impression taking and preparation of models for partial dentures. Zahnarztliche Praxis 22(12): 141-142
Wajs, S.; Chmielewski, W. 1982: 2-stage functional impressions. Protetyka Stomatologiczna 32(4): 147-152
Mériaux, J.L.; Leviet, D.; Lemerle, J.P.; Vilain, R. 1984: 2-stage grafts of flexor tendons. Analysis of a series of 67 cases. Revue de Chirurgie Orthopedique et Reparatrice de l'Appareil Moteur 70(Suppl 2): 64-67
Berezovskiĭ, K.K.; Panichkin, I.V.; Savenko, I.I. 1982: 2-stage implantation of an endocardial stimulator and electrocardiostimulator in heart block. Grudnaia Khirurgiia 4: 15-20
Zechini, F.; Sorgi, G.; Gucciardo, G.; Reale, R.; Panucci, A.; Persia, A.; Bizzarri, C. 1980: 2-stage lacerations and occult lacerations of the spleen: anatomo-clinical aspects and general considerations on the early diagnosis of hemoperitoneum. Chirurgia Italiana 32(4): 914-928
Gruchalski, J.; Grabowski, K. 1981: 2-stage operation for cryptorchism using a silastic membrane. Wiadomosci Lekarskie 34(8): 653-655
Belousov, A.E.; Gubochkin, N.G.; Shvyrev, S.P. 1993: 2-stage plastic repair of the flexor tendons of the fingers: the indications and technic. Vestnik Khirurgii Imeni I. I. Grekova 150(1-2): 57-60
Wasowski, J.; Wajda, Z. 1970: 2-stage post-traumatic rupture of the aorta. Polski Przeglad Chirurgiczny 42(7): 1116-1117
Kozlowska-Klopotowska, C. 1970: 2-stage prosthetic management of closed-bite. Protetyka Stomatologiczna 20(6): 415-420
Ekimov, B.; Petkov, V.; Iordanov, I. 1969: 2-stage prosthetic method in the presence of a previous full denture. Stomatologiia. Stomatology 51(5): 359-361
Edakuni, S.; Takeoka, A.; Kakegawa, T. 1983: 2-stage reconstruction in synchronous stenosis of the trachea and bronchus: a case report. Nihon Kyobu Geka Gakkai 31(3): 377-382
Molski, K.; Turecki, E. 1973: 2-stage reduction of inveterate dislocation of the cervical spine. Chirurgia Narzadow Ruchu i Ortopedia Polska 38(3): 271-275
Spirin, V.A.; Akkerman, G.D. 1970: 2-stage renal angiography and its diagnostic value. Urologiia i Nefrologiia 35(1): 37-40
Shimada, M.; Tsunemoto, M.; Ota, Y.; Naganuma, M.; Yoshitake, K. 1982: 2-stage repair of complete form of common atrioventricular orifice. Rinsho Kyobu Geka 2(3): 352-360
Jović, D.; Pavlović, P.; Kocić, Z. 1974: 2-stage restoration of deep carious lesions by plastic or cast fillings. Stomatoloski Glasnik Srbije 21(5): 321-325
Porcaro, B.E. 1980: 2-stage rupture of the left colon and sigmoid in a case of bilateral presacral ectopic kidney. Minerva Dietologica E Gastroenterologica 26(3): 211-214
Pollak, S.; Reiter, C.; Stellwag-Carion, C. 1984: 2-stage rupture of the liver as a complication of external heart massage. Zeitschrift für Rechtsmedizin. Journal of Legal Medicine 92(1): 67-75
Nikhinson, R.A.; Kir'ianov, A.B.; Chernykh, A.N. 1994: 2-stage rupture of the liver combined with an injury to the hepatic duct and choledochus. Vestnik Khirurgii Imeni I. I. Grekova 152(3-4): 42-43
Vlakhov, N.; Vylkanov, P. 1983: 2-stage scintigraphy of the brain as a method of diagnosing vascular anomalies. Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 4: 33-36
Parszewski, M.; Stoczyński, J.; Cybulska, A. 1973: 2-stage splenic rupture with coexisting left-side hemothorax. Wiadomosci Lekarskie 26(12): 1155-1156
Andrä, A. 1966: 2-stage surgical repair of cleft palate according to the Schweckendiek method and its results. Osterreichische Zeitschrift für Stomatologie 63(6): 204-211
Fornetti, F.; Giombolini, R.; Leo, C. 1969: 2-stage traumatic rupture of the spleen. Acta Chirurgica Italica 25(2): 261-270
Cherkes-Zade, D.I.; Pirogov, I.F. 1980: 2-stage treatment of inveterate fracture-dislocations in Lisfranc's joint. Ortopediia Travmatologiia i Protezirovanie 1: 41-44
Sarkisov, M.A. 1970: 2-staged osteoplastic amputation and reamputation of the extremities in infected wounds. Vestnik Khirurgii Imeni I. I. Grekova 104(5): 90-93
Gurzadian, G.G.; Nikogosian, D.N. 1984: 2-step excitation of the bases composing DNA and RNA biopolymers. Doklady Akademii Nauk SSSR 276(3): 628-631
Laszig, G.; Wüstenberg, H. 1966: 2-step foreign body aspiration in a child. Kinderarztliche Praxis 34(11): 497-501
Utsumomiya, H.; Tsunemoto, M.; Ohta, Y.; Shimada, M.; Mashiko, K.; Yamanaka, H.; Naganuma, M.; Koike, K.; Takano, Y. 1983: 2-step operation of pulmonary atresia with intact ventricular septum and hypoplastic right ventricle. Nihon Kyobu Geka Gakkai 31(12): 2209-2213
Furukawa, S.; Ohmi, M.; Mohri, H. 1983: 2-step sternal closure following open heart surgery in infants. Nihon Kyobu Geka Gakkai 31(11): 2098-2101
Blauth, W. 1984: 2-strip substitution-plasty of the anterior cruciate ligament with the quadriceps tendon. Unfallheilkunde 87(2): 45-51
Malesani, G.; Chiarelotto, G.; Marcolin, F.; Rodighiero, G. 1970: 2-substituted derivatives of 4,7-dihydroxyindoles. Il Farmaco; Edizione Scientifica 25(12): 972-984
Mazzola, U. 1968: 2-sulfanilamido-3-methoxypyridazine (Kelfizin) in the therapy of trachoma. Bollettino d'Oculistica 47(6): 417-424
Della Corte, L.; Sgaragli, G. 1984: 2-t-Butyl-4-methoxyphenol (BHA) acute toxicity in rodents: influence of the administration route. Pharmacological Research Communications 16(10): 1041-1047
Schut, R.N.; Ward, F.E.; Lorenzetti, O.J.; Hong, E. 1970: 2-tetrahydropyridylindoles as histamine and serotonin antagonists. Journal of Medicinal Chemistry 13(3): 394-397
Barker, J.M.; Byron, D.J.; Huddleston, P.R. 1969: 2-thienyl analogues of ephedrine and psi-ephedrine. Journal of the Chemical Society. Perkin Transactions 1 16: 2183-2185
Harnden, M.R.; Short, J.H. 1967: 2-thio-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo[a]quinolizines. Journal of Medicinal Chemistry 10(6): 1183-1184
Choong, Y.S.; Massey, V. 1983: 2-thioriboflavin 5'-phosphate (2-thio-FMN) lactate oxidase. European Journal of Biochemistry 131(3): 501-508
Goodrich, M.E.; Cardeilhac, P. 1970: 2-thiouridine 5'-phosphate and its inhibition of aspartate transcarbamylase. Biochimica et Biophysica Acta 222(3): 621-626
Sadykhov, A.G.; Askerov, A.M.; Pauker, A.V. 1974: 2-tissue malignant degeneration of a long-term functioning osteomyelitic fistula. Arkhiv Patologii 36(8): 75-79
Barabolia, V.F. 1972: 2-toothed osteotome. Ortopediia Travmatologiia i Protezirovanie 33(7): 70-71
McEvoy, F.J.; Greenblatt, E.N.; Osterberg, A.C.; Allen, G.R. 1970: 2-trifluoromethoxydibenz [b,e][1,4] diazepine and 2-trifluoromethoxydibenz [b,f][1,4]-oxazepine derivatives. Journal of Medicinal Chemistry 13(2): 295-297
Ennis, B.C.; Holan, G.; Samuel, E.L. 1967: 2-trihalogenomethylbenzazoles. 3. Reactions of 2-trichloromethylbenzimidazole with nucleophiles. Journal of the Chemical Society. Perkin Transactions 1 1: 30-33
Holan, G.; Samuel, E.L.; Ennis, B.C.; Hinde, R.W. 1967: 2-trihalogenomethylbenzazoles. I. Formation. Journal of the Chemical Society. Perkin Transactions 1 1: 20-25
Holan, G.; Samuel, E.L. 1967: 2-trihalogenomethylbenzazoles. II. Reactions of 2-trihalogenomethylbenzimidazoles with ammonia and amines. Journal of the Chemical Society. Perkin Transactions 1 1: 25-29
Ennis, B.C.; Holan, G.; Samuel, E.L. 1967: 2-trihalogenomethylbenzazoles. IV. Reactions with difunctional nucleophiles. Formation of heterocyclic rings on the 2-position of benzazoles. Journal of the Chemical Society. Perkin Transactions 1 1: 33-39
Selivanova, G.V.; Vlasova, T.D. 1982: 2-wave-length method for the quantitative determination of DNA and histones in the same cell nucleus. Tsitologiia 24(3): 293-299
Asratian, E.A. 1981: 2-way connection as a general neurophysiologic principle. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 31(1): 3-11
Sugiki, K. 1982: 2-year clinical experience in the United States--status of surgical therapy of acute ischemic heart disease in southern California. Rinsho Kyobu Geka 2(2): 303-305
Ikehira, H.; Smith, F.W.; Reid, A. 1983: 2-year clinical experience with nuclear magnetic resonance imaging at Aberdeen University--a report on the magnetic injuries and protection of the human body. Kaku Igaku. Japanese Journal of Nuclear Medicine 20(3): 349-352
Jodkowska, E. 1984: 2-year clinical follow-up after application of Concise Enamel Bond System for sealing defects in the occluding surfaces of teeth. Czasopismo Stomatologiczne 37(11): 839-846
Schumacher, W. 1965: 2-year clinical observations on the use of rapid electrons of the 35 MeV betatron. Strahlentherapie. Sonderbande 61: 74-81
Friedman, W.W. 1970: 2-year clinical results with endosseous implants. Dental Survey 46(12): 30-32
Jodkowska, E. 1984: 2-year clinical studies after application of Nuva-Seal sealing material. Czasopismo Stomatologiczne 37(12): 917-929
Laccourreye, H.; Haguet, J.F.; Prat, C.; Aboudarham, J.F. 1974: 2-year computerized statistical study of the efficacy of supplementary antimitotic treatment of cancers of the larynx and pharynx. Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 91(12): 641-656
Fritze, E. 1973: 2-year experience with a programmed case history interview. Deutsche Medizinische Wochenschrift 98(45): 2159-2161
Braun, W. 1965: 2-year experiences and conclusions from a Microsporia epidemic in the Magdeburg area. Das Deutsche Gesundheitswesen 20(25): 1147-1148